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ABSTRACT OF DISSERTATION 
 
 
 
 
MECHANISTIC INVESTIGATIONS OF THE TRANS EXCISION-SPLICING AND 
TRANS INSERTION-SPLICING REACTION 
 
Group I intron-derived ribozymes are catalytic RNAs that have been engineered 
to catalyze a variety of different reactions, in addition to the native self-splicing reaction. 
One such ribozyme, derived from a group I intron of Pneumocystis carinii, can modify 
RNA transcripts through either the excision or insertion of RNA sequences. These 
reactions are mediated through the trans excision-splicing (TES) or trans insertion-
splicing (TIS) reaction pathways. To increase our current understanding of these 
reactions, as well as their general applicability, a mechanistic and kinetic framework for 
the TES reaction was established. Furthermore, additional ribozymes were investigated 
for their ability to catalyze the TES reaction. Lastly, the development of the TIS reaction 
into a viable strategy for the manipulation of RNA transcripts was investigated. 
 The TES reaction proceeds through two reaction steps: substrate cleavage 
followed by exon ligation. Mechanistic studies revealed that substrate cleavage is 
catalyzed by the 3’ terminal guanosine of the Pneumocystis ribozyme. Moreover, kinetic 
studies suggest that a conformational change exists between the individual reaction steps. 
Intron-derived ribozymes from Tetrahymena thermophila and Candida albicans were 
also investigated for their propensity to catalyze the TES reaction. The results showed 
that each ribozyme could catalyze the TES reaction; however, Pneumocystis carinii is the 
most effective using the model constructs. 
 Investigations of the TIS reaction focused on developing a new strategy for the 
insertion of modified oligonucleotides into an RNA substrate. These studies used 
oligonucleotides with modifications to the sugar, base, and backbone positions. Each of 
the modified oligonucleotides was shown to be an effective TIS substrate. These results 
demonstrate that TIS is a viable strategy for the incorporation of modified 
oligonucleotides, of varying composition, into an intended RNA target.  
The results from these studies show that group I introns are highly adaptable for 
catalyzing non-native reactions, including the TES and TIS reactions. Furthermore, group 
I introns are capable of catalyzing these unique reactions through distinct reaction 
pathways. Overall, these results demonstrate that group I introns are multi-faceted 
catalysts.  
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CHAPTER ONE-SUMMARY 
 
 Ribonucleic acids, or RNA, are vital biomolecules in that they play a pivotal role 
in the pathway by which the genetic information stored within a cell is expressed. Prior to 
the 1980’s, the role of RNA was thought to be an intermediate in the pathway of 
expression of proteins from deoxyribonucleic acids (DNA). The discovery of catalytic 
RNA resulted in the reclassification of RNA (1, 2). These discoveries ultimately led to 
the identification of many catalytic RNAs which are found in a variety of differing 
organisms. These include plants, bacteria, viruses, lower eukaryotes, and a few mammals 
(3-7). In the last twenty-five years, the manipulation of these catalytic RNAs, termed 
ribozymes, has shown that they can perform a variety of enzymatic reactions previously 
thought to be catalyzed only by protein enzymes (3, 6).  
 One previously characterized ribozyme-mediated reaction, catalyzed by a group I 
intron-derived ribozyme from the fungal pathogen Pneumocystis carinii, results in the 
site-specific excision of predefined regions from within RNA transcripts (8). The 
reaction, termed trans excision-splicing (TES), has previously been shown to be a viable 
strategy for the manipulation of RNA sequences in vitro, as well as in vivo (8, 9). The 
manipulation of RNA sequences, particularly in vivo, could potentially lead to the 
development of TES into a therapeutic strategy for the correction of mutated RNA 
transcripts (9). The TES reaction also provides a unique model system for the study of 
RNA catalysis.  
 Another recently characterized ribozyme-mediated reaction, termed trans 
insertion-splicing (TIS), has been developed for the site-specific insertion of 
oligonucleotides into RNA transcripts (10). Similar to the TES reaction, the TIS reaction 
is catalyzed by a group I intron-derived ribozyme from Pneumocystis carinii (10). The 
TIS reaction has potential as a strategy for the manipulation of RNA sequences, 
specifically the insertion of modified oligonucleotides into RNA transcripts. 
Previous investigations of the TES reaction have led to questions relating to the 
overall reaction mechanism, specifically regarding the first reaction step. The research 
presented herein investigates the fine details of the TES reaction through mechanistic as 
well as kinetic characterization of the first reaction step of TES. Furthermore, ribozymes 
1 
other than that from Pneumocystis carinii were investigated for their ability to catalyze 
the TES reaction. With respect to the TIS reaction, the potential of TIS being developed 
into a viable strategy for the insertion of modified oligonucleotides was investigated to 
ascertain its feasibility.  
 
Investigation of the Reaction Mechanism for the Trans Excision-Splicing Reaction 
 Previous investigations of the TES reaction suggest the first reaction step 
(substrate cleavage) was catalyzed through ribozyme-mediated 5’ hydrolysis (8). An 
alternative explanation is that an endogenous nucleotide, specifically one at the 3’ 
terminal position of the ribozyme, acts as an intramolecular nucleophile. In this case, 
substrate cleavage is catalyzed through ribozyme-mediated intramolecular 
transesterification. To distinguish between the two possible reaction mechanisms, the 
unique reaction intermediates that would be produced in each mechanism were analyzed. 
 The results demonstrate that the substrate cleavage reaction of TES is catalyzed 
through ribozyme-mediated intramolecular transesterification. Specifically, the 3’ 
terminal guanosine of the ribozyme acts as an intramolecular nucleophile. This 
conclusion is based on several lines of evidence, including the isolation of TES ribozyme 
intermediates from previously characterized in vitro and in vivo model systems. 
Sequencing of TES ribozyme intermediates demonstrate a portion of the RNA substrate 
becomes covalently attached to the 3’-end of the ribozyme. Surprisingly, TES ribozyme 
intermediates isolated in vivo demonstrate that the ribozyme undergoes a self-truncation 
process, thereby acquiring a reactive 3’ terminal guanosine. These results have greatly 
enhanced our current understanding of the overall mechanism for the TES reaction. For 
future TES studies, the mechanistic insights gained will potentially lead to an increase in 
the likelihood of successful TES reactions conducted in vitro and in vivo. 
 
 
Kinetic Characterization of the First Step of the TES Reaction 
Previous investigations of ribozyme-mediated reactions have established kinetic 
frameworks for gaining insight into the fundamental aspects of RNA catalysis. These 
previous studies have been informative with regard to the chemical and mechanistic 
2 
aspects of ribozyme-mediated reactions. Previously, a possible mechanistic pathway for 
the first and second reaction steps of the TES reaction has been proposed based on our 
current understanding of other ribozyme-mediated reactions (8, 11-17). Prior TES 
reports, however, have not focused on the individual reaction steps in detail, and rate 
constants for individual steps have not been determined. Thus, a minimal kinetic scheme, 
in conjunction with another member of the Testa lab (Joy Sinha), was established for the 
first step of the TES reaction. These studies were undertaken to increase our fundamental 
understanding of the mechanism for TES, as well as for RNA catalysis in general.  
The results obtained from the kinetic scheme for the first reaction step (substrate 
cleavage) showed that the rate constants for both substrate cleavage and substrate 
dissociation are comparable and that the true rate for the chemical step is being masked 
by a conformational change. Additionally, the relatively slow rate of product dissociation 
suggests that it is rate-limiting with respect to the possibility of multiple-turnover 
reactions. The insights obtained have greatly enhanced our current understanding of the 
fine details with respect to the first step of the TES reaction.  
 
The Trans Excision-Splicing Reaction Can be Catalyzed by Group I Intron-Derived 
Ribozymes from Tetrahymena thermophila and Candida albicans 
 Previous investigations of the TES reaction have focused on the group I intron-
derived ribozyme from Pneumocystis carinii (8, 9, 18, 19). Structurally, previously 
characterized intron-derived ribozymes are similar to Pneumocystis carinii in that all the 
fundamental structural elements required to perform the TES reaction are present. This 
suggests that other group I intron-derived ribozymes could potentially catalyze the TES 
reaction. If true, it would be informative to know the relative effectiveness of these 
ribozymes. To address this possibility, the group I intron-derived ribozymes from 
Tetrahymena thermophila and Candida albicans were modified to investigate their ability 
to catalyze the TES reaction.  
 The results demonstrate that the intron-derived ribozymes from Tetrahymena 
thermophila and Candida albicans can catalyze the excision of a single nucleotide from 
within respective RNA substrates. In addition, both ribozyme constructs catalyze the 
substrate cleavage reaction through ribozyme-mediated intramolecular transesterification. 
3 
Both ribozyme constructs, however, show decreased efficiencies for catalyzing the 
individual steps of the TES reaction compared to the Pneumocystis carinii ribozyme. 
This was determined to be due to the individual ribozyme’s ability to effectively utilize 
their 3’ terminal guanosine as an intramolecular nucleophile. Nevertheless, our results 
show that the TES reaction can be catalyzed by at least three different group I intron-
derived ribozymes. Apparently, being able to catalyze the TES reaction is a common 
property of group I intron-derived ribozymes. 
 
Insertion of Modified Oligonucleotides using the Trans Insertion-Splicing Reaction 
 The site-specific modification of RNA transcripts has lead to more in-depth 
studies of the structural and functional aspects of RNA. Current methods for synthesizing 
full-length modified RNA transcripts, however, have been problematic, in some cases 
suffering from a lack of product specificity and low product yields. The TIS reaction was 
recently developed to site-specifically insert oligonucleotides into a RNA substrate (10). 
The next step is to determine whether the TIS reaction could be developed into a new 
methodology for the insertion of modified oligonucleotides into RNA transcripts. To test 
the feasibility of this strategy, a test system was developed that uses modified 
oligonucleotides as TIS substrates, including substrates with single and double 
modifications. For this proof-of-principle study, five modifications were used, including 
those to the ribose sugar (deoxy or methoxy substitution), base (2-aminopurine or 4-
thiouridine), or phosphodiester backbone (thiol substitution).  
The results demonstrate that the TIS reaction is a viable strategy for the insertion 
of modified oligonucleotides into RNA targets. For the five modified oligonucleotides 
tested, each was inserted sequence-specifically into their intended RNA targets, and 
yields ranged from 60-70%. Furthermore, the TIS strategy was shown to be effective at 
inserting oligonucleotides with double modifications. These results are encouraging in 
that the TIS strategy is potentially a new method for the synthesis of full-length modified 
RNA transcripts. 
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CHAPTER TWO-BACKGROUND 
 
The Central Dogma of Molecular Biology. 
In 1958 (20), Francis Crick proposed ‘the central dogma of molecular biology’ to 
describe the flow of genetic information within a cell (Figure 2.1). In all known cell 
types, the genetic information is found in the form of deoxyribonucleic acids, or DNA. 
For the information contained within cellular DNA to be converted into something 
useful, the DNA is first used as a template for the production of ribonucleic acids, or 
RNA. This process, known as transcription, results in a RNA transcript that is identical to 
the sequence of the DNA except for the substitution of thymine for uracil (see following 
sections). The resulting RNA transcript is further modified post-transcriptionally to yield 
the mature RNA species. 
In the case of messenger RNA, the resulting RNA transcript is subsequently used 
as a template for the production of a protein product through the process of translation. 
Messenger RNA transcripts are divided into groups of three consecutive RNA residues, 
termed codons, that code for the twenty naturally occurring amino acids. During 
translation, each amino acid is subsequently added to the elongating polypeptide chain, 
through the formation of peptide bonds. The resulting protein product is further modified 
post-translationally, in some instances, to yield the final protein product. In later studies, 
RNA was also found to be used as a template for the synthesis of a complementary DNA 
molecule. These later discoveries, including reverse transcription, resulted in the 
modification of the overall scheme of the central dogma (21). 
 
Nucleic Acids 
 Nucleic acids are naturally occurring biopolymers consisting of the monomeric 
subunits termed nucleotides. The two classes of nucleic acids, deoxyribonucleic and 
ribonucleic acids differ structurally, which contribute to their unique chemical and 
functional properties.  
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Deoxyribonucleic Acid 
 Deoxyribonucleic acid, or DNA, consists of a 2’-deoxyribose sugar with three 
distinct components attached (Figure 2.2A). These include a 3’ hydroxyl group, a 
heterocyclic nucleobase, and a 5’ phosphate group (22). DNA can be further 
differentiated into four distinct nucleotides by the identity of the heterocyclic nucleobase. 
Purines, which include adenine (A) and guanine (G), and pyrimidines, which include 
thymine (T) and cytosine (C) (Figure 2.3). Note that purines are monocyclic compounds 
while pyrimidines are bicyclic compounds.  
Individual nucleotides are attached through phosphodiester bond linkages. This 
occurs through the covalent attachment of a phosphate group between the 5’ hydroxyl of 
one nucleotide to the 3’ hydroxyl of an adjacent nucleotide. Note, the resulting 
phosphodiester backbone of DNA has directionality in the 5’ to 3’ direction (Figure 2.4). 
Additionally, DNA is typically encountered in a double-stranded form, with each strand 
being oriented in an anti-parallel fashion. The two strands are complementary to one 
another with each type of base on one strand forming a bond with only one type of base 
on the other strand (22). The bonding, termed base-pairing, between the individual DNA 
nucleobases is through hydrogen bonding (Figure 2.5). Base-pairing typically occurs 
between purines and pyrimidines resulting in the normal Watson-Crick base-pairs. 
 
Ribonucleic Acid 
 Ribonucleic acid, or RNA, consists of a ribose sugar ring with three separate 
components attached to the sugar ring (Figure 2.2B). These include a 3’ hydroxyl group, 
a heterocyclic nucleobase, and a 5’ phosphate group (22) Similar to DNA, RNA can be 
differentiated into four distinct nucleotides by the identity of the heterocyclic nucleobase. 
These include purines and pyrimidines (22). RNA differs from DNA, however, in that the 
2’ position of the ribose sugar is a hydroxyl group (Figure 2.2B). Additionally, the 
nucleobase identity is changed from uracil (U) instead of thymine (T), which differs in 
that a methyl group is replaced by hydrogen within the nitrogenous ring of thymine 
(Figure 2.3). Lastly, RNA is typically encountered in a single-stranded form having 
directionality in the 5’ to 3’ direction. 
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That RNA is typically encountered in a single-stranded form renders RNA 
capable of forming complex three-dimensional structures. RNA folding results in base-
pairing between complementary regions within the RNA itself. These base-paired regions 
make-up the secondary, and in some cases tertiary, structures encountered for RNA. 
Examples of a few of the secondary structural elements that can be encountered for RNA 
species include duplexes, hairpins, bulges, loops, and junctions (Figure 2.6). These 
secondary structures, which contribute to the final tertiary structure, result in the complex 
shapes that RNA can acquire to perform various functions in vivo, including catalysis. 
 
Catalytic RNA 
 Until the early 1980’s, protein enzymes were thought to be the only biological 
species capable of performing enzymatic reactions. In 1982, an RNA species was 
demonstrated to be capable of catalyzing the cleavage-ligation of phosphodiester bonds 
in the absence of proteins (1). In this case, the intervening sequence within the large 
ribosomal RNA (rRNA) subunit of Tetrahymena thermophila was found to act as a 
catalyst. The autoexcision reaction, catalyzed by these introns, was later termed the self-
splicing reaction. Simultaneously, the active site of ribonuclease P, isolated from 
Escherichia coli and Bacillus subtilis, was determined to be composed of RNA (2).  
Since the discovery of catalytic RNAs, also called ribozymes, several catalytic RNA 
species have been discovered. These include the hammerhead (23), hairpin (24), hepatitis 
delta virus (25), Varkud satellite (26), group I and group II introns (1, 27-29), 
ribonuclease P (2), and most recently the glmS ribozyme (30). 
 
RNA Splicing 
For some prokaryotic and eukaryotic cells, exon sequences are interrupted by an 
intervening sequence (IVS), or intron. Prior to the formation of a mature RNA species, 
the intron sequence is excised from within their flanking exon sequences. Currently, four 
major classes of introns have been described based upon their mechanism of excision (31, 
32). These include group I and group II introns, tRNA introns, and the spliceosomal 
introns found within nuclear pre-mRNA (31, 32). For many group I and group II introns, 
the introns themselves catalyze their own excision through separate self-splicing reaction 
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pathways (31, 32). Note, for other group I and group II introns, proteins are required to 
facilitate their splicing (1, 33). As for tRNA introns, the introns are excised through 
enzymatic cleavage and ligation of the precursor RNA (31, 32). In the case of 
spliceosomal introns, the intron is excised through the complex machinery of the 
spliceosome (34). 
 
Group I Introns 
Group I introns have been found in the precursor mRNA, tRNA, and rRNA 
transcripts in a variety of different cell types, including prokaryotes, yeast, fungi, and 
viruses (3, 35). To date, more than 2000 group I introns are known (35). They range in 
size from a few hundred nucleotides to approximately 3000 nucleotides (35). In general, 
group I introns are composed of a common core of secondary structures, consisting of 10 
to 17 base-paired regions termed P1-P17 (38-39). Upon folding, these base-paired 
regions constitute the active form of the intron (Figure 2.7).  
Specific regions within group I introns are employed for binding and alignment of 
substrates (5’ and 3’ exon sequences) and cofactors used during the self-splicing reaction. 
Molecular recognition elements (REs) are employed to bind the substrates for the 
subsequent self-splicing reaction. The 5’ exon region is bound through recognition 
element 1 (RE1) to form the P1 helix (40-42) (Figure 2.8). The 3’ exon region is bound 
through recognition element 3 (RE3) to form helix P10 (40). The intron binds itself 
intramolecularly through recognition element 2 (RE2) to form the P9.0 helix (43, 44). 
Note the nucleotides that encompass RE1 and RE3, which are part of the P1 and P10 
helices, are termed the internal guide sequence (IGS), in some instances. A specific 
region, within the P7 region of the intron, termed the guanosine-binding site (GBS) binds 
the two consecutive guanosine residues used in the self-splicing reaction (see section 
titled The Self-Splicing Reaction) (45-47). 
Specific reaction sites within the exon and intron sequences define the positions 
of splicing, termed splice sites. For the self-splicing reaction, two splice sites (the 5’ and 
3’ splice sites) determine the location where the two consecutive transesterification 
reactions of the self-splicing reaction occur. The 5’ splice site is defined as the 
phosphodiester backbone that is 3’ to the last nucleotide of the 5’ exon (Figure 2.8). A 
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uridine residue is typically (cytosine being the only exception) the last nucleotide of the 
5’ exon and forms a wobble base-pair (G•U) to a conserved guanosine within RE1 of the 
intron (48-53). The 3’ splice site is defined as the phosphodiester backbone 3’ to a 
conserved guanosine residue located at the 3’ terminal position of the intron, termed ωG. 
Group I introns are also metalloenzymes in that they require metal ions to 
facilitate the proper folding of the intron into its active form (54-56). In addition, metal 
ions have been implicated in aiding in the individual steps of the self-splicing reaction. 
Divalent metal ions, especially magnesium (Mg2+), are the preferred ion. Monovalent 
metal ions, including sodium (Na+) or potassium (K+), are acceptable, albeit at higher 
concentrations (54-56).  
 
The Self-Splicing Reaction 
 The self-splicing reaction consists of two consecutive transesterification reactions, 
ultimately resulting in the excision of the intron and ligation of the flanking 5’ and 3’ 
exons. In the first reaction step, termed substrate cleavage, the intron binds an exogenous 
guanosine cofactor into the GBS (Figure 2.9A) (57). This exogenous guanosine can be 
any of the 5’ phosphorylated derivatives of guanosine triphosphate (GMP, GDP, or 
GTP). The 3’ hydroxyl group of the guanosine performs a nucleophilic attack upon the 5’ 
splice site, resulting in cleavage of the phosphodiester backbone between the 3’-end of 
the 5’ exon and the 5’-end of the intron. The direct result of substrate cleavage is the 
covalent attachment of the exogenous guanosine to the 5’-end of the intron (Figure 2.9A) 
(11, 58).  
Prior to the second step of the self-splicing reaction (exon ligation), a proposed 
conformational change occurs, resulting in the expulsion of the exogenous guanosine 
cofactor from the GBS (46, 47, 59). This conformational change facilitates the 
preferential binding of ωG of the intron. The alignment of ωG into the GBS is 
accomplished by formation of both the P10 and P9.0 helices (60-66). For the exon 
ligation reaction step, the newly formed 3’ hydroxyl group of the uridine at the 3’-end of 
the 5’ exon performs a nucleophilic attack upon the 3’ splice site of the intron, resulting 
in the ligation of the 5’ and 3’ exons (Figure 2.9A).  
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 The final excised intron product, termed the linear intervening sequence, or L-
IVS, can undergo subsequent cyclization reactions that result in the intron self-processing 
itself into a circular form (67-70). In the cyclization reaction, the L-IVS binds a portion 
of the 5’-end of the intron through RE1 to form a P1 helix, resulting in the establishment 
of a new 5’ splice site (Figure 2.9B). The L-IVS catalyzes an intramolecular 
transesterification reaction, resulting in the covalent attachment of the 5’ and 3’-ends of 
the L-IVS. The intramolecular transesterification reaction is catalyzed by the 3’ terminal 
guanosine, ωG, of the L-IVS. Overall, the reaction results in a circularized intron product, 
termed the circular intervening sequence, or C-IVS (Figure 2.9B).  
 
Group I Intron-Derived Ribozymes 
To further elucidate the overall mechanism of the self-splicing reaction, group I 
introns have been modified by removal of their native 5’ and 3’ exon sequences (Figure 
2.9). The new catalytic RNA species, known as group I intron-derived ribozymes, were 
designed so that the individual steps of the self-splicing reaction could be investigated. Of 
these group I intron-derived ribozymes, the Tetrahymena thermophila ribozyme (71) has 
been the most extensively studied of these ribozymes. Other group I intron-derived 
ribozymes, however, have been constructed. These include the intron-derived ribozymes 
from Anabaena (72), Azoarcus (73), Candida albicans (74), and Pneumocystis carinii 
(75). Group I intron-derived ribozymes have been shown to be capable of reaction rate 
enhancements similar to enzyme catalysts and are capable of multiple-turnover reactions 
(71-74).  
Group I intron-derived ribozymes have been shown to be capable of catalyzing 
additional non-native reactions, including ribonuclease (14, 15), phosphatase (13), 
polymerization (76, 77), recombination (78), reverse-splicing (79, 80), trans-splicing (81-
90), trans excision-splicing (8), trans insertion-splicing (10), and 5’ replacement reactions 
(91). That group I intron-derived ribozyme can catalyze additional reactions demonstrates 
the multi-faceted nature of these catalysts. 
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The Trans Excision-Splicing Reaction 
 The trans excision-splicing (TES) reaction, catalyzed by a group I intron-derived 
ribozyme from the opportunistic pathogen Pneumocystis carinii, was developed to 
sequence specifically excise a targeted sequence from within an RNA substrate (Figure 
2.10) (8). The TES reaction consists of two consecutive transesterification reactions that 
are similar to those of the self-splicing reaction. These consist of substrate cleavage 
followed by exon ligation. The TES reaction has previously been shown to be capable of 
excising as little as one nucleotide and as many as twenty-eight nucleotides from within 
RNA substrates (8). Most recently, the TES reaction was shown to be an effective 
strategy for the manipulation of RNA transcripts in vivo utilizing an Escherichia coli 
model system (9).  
As seen for intron-catalyzed self-splicing, TES ribozymes appear to utilize the 
same molecular recognition elements for orienting their substrates and intermediates 
during the TES reaction. The 5’ exon region is bound through recognition element 1 
(RE1) to form the P1 helix (Figure 2.10).  The 3’ exon region is bound through 
recognition element 3 (RE3) to form the P10 helix. For TES reactions resulting in the 
excision of more than one nucleotide, the bridge region is bound through recognition 
element 2 (RE2) to form the P9.0 helix (Figure 2.10). Though previous investigations 
have shown that formation of helix P10 and P9.0 are beneficial for the overall TES 
reaction, neither is required (18, 19).  
In the first reaction step (substrate cleavage), the Pneumocystis carinii ribozyme 
mediates the cleavage of the phosphodiester backbone located at the 3’-end of the 5’ exon 
region (Figure 2.10). Therefore, for TES, the 5’ splice site is determined as the 3’-end of 
helix P1. Under optimal TES conditions, a G•U wobble base-pair is formed at the 5’ 
splice site, however, other base-pair combinations have been substituted successively 
(19). These include Watson-Crick base-pairs, though decreased TES product yields were 
observed (19).  
For the second reaction step (exon ligation), the nucleophilic 5’ exon attacks the 
phosphodiester backbone 3’ of a specific guanosine, termed ωG, within the substrate. The 
ωG, which aids in defining the 3’ splice site, is defined as the border between the bridge 
region and the 3’ exon region (Figure 2.10). Furthermore, previous investigations have 
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shown that only a guanosine can be defined at the ω-position of the substrate (19). The 
products of exon ligation consist of the final TES product (ligated 5’ and 3’ exon 
sequences) and the bridge region covalently attached to the ribozyme (Figure 2.10).  
 
The Trans Insertion-Splicing Reaction 
The trans insertion-splicing (TIS) reaction, catalyzed by a group I intron-derived 
ribozyme from Pneumocystis carinii, was recently developed to site-specifically insert a 
targeted sequence into an RNA substrate (Figure 2.11) (10). The TIS reaction, which 
utilizes two separate RNA substrates, has been proposed to proceed through three 
separate chemical steps. This includes two consecutive substrate cleavage steps and a 
single exon ligation step (Figure 2.11). As seen for the ribozyme-mediated TES reaction, 
TIS ribozymes appear to utilize the same molecular recognition elements for orienting 
their substrates and intermediates during the TIS reaction. The TIS reaction has 
previously been shown to be capable of catalyzing the insertion of six nucleotides into a 
separate RNA substrate (10). 
In the first reaction step (substrate cleavage), the TIS donor substrate is bound 
through the first three nucleotides of Recognition Element 1 (RE1) to form a partial P1 
helix, termed P1i (Figure 2.11). In addition, the TIS donor substrate is bound through 
Recognition Element 3 (RE3) to form a P10 helix. The 3’ terminal guanosine (G336) of 
the Pneumocystis carinii ribozyme performs a nucleophilic attack upon the 5’ splice site 
(Figure 2.11). The 5’ splice site is defined as the phosphodiester backbone that is 3’ to the 
last nucleotide of the 5’ exon region. The result of the substrate cleavage reaction is the 
covalent attachment of the insert region of the TIS donor substrate to the 3’-end of the 
Pneumocystis carinii ribozyme. After the substrate cleavage reaction, the 5’ exon region 
of the TIS donor substrate dissociates from the ribozyme (Figure 2.11).  
Prior to the second reaction step, the ribozyme binds the 5’ exon region of the TIS 
acceptor substrate through RE1 to form a new P1 helix (Figure 2.11). In the second 
reaction step (substrate cleavage), the 3’ terminal guanosine of the insert region, termed 
ωGi, performs a nucleophilic attack upon the new 5’ splice site (Figure 2.11). In this 
case, the 5’ splice site is defined as the phosphodiester backbone that is 3’ to the last 
nucleotide of the 5’ exon region. Substrate cleavage results in the covalent attachment of 
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the 3’ exon region of the TIS acceptor substrate to the 3’-end of the Pneumocystis carinii 
ribozyme (Figure 2.11).  
Prior to the final step of the TIS reaction, a proposed conformational change 
occurs, which displaces ωGi from the GBS. This results in preferential binding of G336 
of the ribozyme to the GBS, which aids in defining the 3’ splice site. The alignment of 
G336 into the GBS is thought to occur through reformation of helix P10. In the third 
reaction step (exon ligation), the 3’ hydroxyl group of uridine performs a nucleophilic 
attack upon the phosphodiester backbone 3’ to G336. This results in final TIS product 
formation, including ligation of 5’ exon region to the 3’ exon region, including the 
incorporation of the insert (Figure 2.11).  
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Figure 2.1. The central dogma of molecular biology. Deoxyribonucleic acids, or DNA, 
are the biological macromolecule that contain all the genetic information of a cell, and is 
typically found in a double helical form. Prior to cell replication, DNA is replicated so 
that an identical copy of the parental DNA is passed to each successive generation. The 
genetic information stored in DNA is first transcribed to ribonucleic acids, or RNA, and 
is then translated to protein. Additionally, RNA can be used as a template for the creation 
of DNA through reverse transcription.  
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Figure 2.2. Structure of a deoxy and ribonucleotide. A. Diagram of a deoxyribonucleotide 
including the distinct functional groups attached to the pentose sugar ring including the 
nucleobase, hydroxyl, and phosphate groups. B. Diagram of a ribonucleotide including 
the distinct functional groups attached to the pentose sugar ring including the nucleobase, 
hydroxyl, and phosphate groups. Ribonucleotides differ from their deoxyribonucleotide 
counterparts in that a hydroxyl group is substituted at the 2’ position of the sugar ring. 
For the case of DNA and RNA, the identity of the nucleobase distinguishes the four 
nucleotides.  
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Figure 2.3. Nucleobases encountered in DNA and RNA. The nucleobases encountered for 
DNA and RNA are separated into bicyclic purines and monocyclic pyrimidines. Purines 
include adenine and guanine, and pyrimidines include thymine, uracil, and cytosine. 
DNA consists of the adenine, guanosine, thymine, and cytosine nucleobases. RNA 
consists of adenine, guanosine, uracil, and cytosine nucleobases. The individual bases are 
typically indicated with their single letter abbreviation; adenine (A), guanine (G), 
thymine (T), uracil (U), and cytosine (C). DNA and RNA sequences are typically denoted 
using single letter abbreviations, which represent the individual nucleotides. 
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Figure 2.4. Directionality of DNA. Diagram of directionality of DNA from the 5’ 
phosphate group to the 3’ hydroxyl group depicting all four nucleotides (A = adenosine, 
G = guanosine, T = thymine, and C = cytosine). Each of the nucleotides is linked through 
a 5’, 3’ phosphodiester bond linkage. An arrow denotes the directionality of the DNA. 
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Figure 2.5. Watson-Crick base-pairing typically encountered in DNA. Diagram of 
Watson-Crick base-pairs found within DNA. The top pair represents the base-pairing 
interaction between adenine and thymine (two hydrogen bonds). For RNA, a base-pair 
between adenine and uracil occurs. The bottom pair represents the base pairing 
interaction between guanine and cytosine (three hydrogen bonds). Note, dR represents 
the deoxyribose sugar. 
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Figure 2.6. Common secondary structures encountered for RNA. Schematic 
representation of common secondary structures encountered for RNA including duplexes, 
bulges, hairpins, internal loops (both symmetrical and asymmetrical), and junctions are 
depicted. 
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Figure 2.7. Sequence and proposed secondary structure of the Pneumocystis carinii group 
I intron. The intron sequence is denoted in black upper case lettering and the exon 
sequences are denoted in gray lowercase lettering. The molecular recognition elements 
(boxed) are shown whereby recognition element 1 (RE1) binds the 5’ exon forming the 
P1 helix. Recognition element 3 (RE3) binds the 3’ exon forming the P10 helix, and the 
intron binds itself intramolecularly through recognition element 2 (RE2) to form the P9.0 
helix. The sites of reaction, termed splice sites, are denoted by arrows. The guanosine-
binding site (GBS) is shown within the P7 region of the intron circled in gray, which 
binds the two consecutive guanosines utilized for the self-splicing reaction. 
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Figure 2.8. The reaction pathway for the self-splicing and cyclization reactions catalyzed 
by group I introns.  A. The self-splicing reaction. The group I intron is denoted by a gray 
line and the 5’ and 3’ exon sequences are denoted by black lines. A black square within 
the 5’ exon region denotes a uridine and a gray circle at the 3’-end of the intron denotes a 
guanosine (ωG). The P1 helix is formed through base-pairing of recognition element 1 
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(RE1) with the 5’ exon. The P10 helix is formed through base-pairing of recognition 
element 3 (RE3) with the 3’ exon. The intron binds itself intramolecularly through 
recognition element 2 (RE2) to form the P9.0 helix. The first reaction step (substrate 
cleavage) is catalyzed by an exogenous guanosine cofactor. Substrate cleavage results in 
covalent attachment of the guanosine to the 5’-end of the intron. The second step (exon 
ligation) proceeds through attack of the uridine upon the ωG of the intron, resulting in 
ligation of the flanking sequences. The resulting intron product is termed the linear 
intervening sequence (L-IVS). B. The cyclization (circularization) reaction catalyzed by 
the L-IVS. The L-IVS binds a portion of the 5’-end of the L-IVS (typically including the 
RE3 region) to form a new P1 helix. An intramolecular transesterification reaction, 
catalyzed by ωG (gray circle at 3’-end of L-IVS) occurs, resulting in the covalent 
attachment of the 5’-end to the 3’-end of the L-IVS. This forms the circular intervening 
sequence (C-IVS). 
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Figure 2.9. Sequence and proposed secondary structure of a Pneumocystis carinii group I 
intron-derived ribozyme. The primary sequence of the group I intron-derived ribozyme is 
essentially identical to the group intron depicted in Figure 2.8. The difference between 
the two sequences is removal of both the 5’ exon and 3’ exon sequences. In addition, 
eight nucleotides are removed from the 5’-end of the intron and four nucleotides are 
removed from the 3’ end of the intron. The molecular recognition elements (shown in 
bold, boxed uppercase lettering) consist of recognition element 1 (RE1), recognition 
element 3 (RE3), and recognition element 2 (RE2) which will be used for formation of 
the P1, P10, and P9.0 helices respectively. 
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Figure 2.10. Diagram of the ribozyme-mediated trans excision-splicing reaction. The 
Pneumocystis carinii ribozyme is denoted in gray lines and the 5’ and 3’ exon sequences 
are denoted by black lines. The black square within the 5’ exon region denotes a uridine 
and the gray circle adjacent to the 3’ exon region denotes a guanosine (ωG). The bridge 
region, to be excised, is denoted as a dotted line. The P1 helix is formed through base-
pairing of recognition element 1 (RE1) with the 5’ exon. The P10 helix is formed through 
base-pairing of recognition element 3 (RE3) with the 3’ exon. The first step (substrate 
cleavage) is catalyzed by G336 (open circle at 3’-end of ribozyme) resulting in the 
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covalent attachment of the 3’-end of the substrate to the 3’-end of the ribozyme. The 
second step (exon ligation) proceeds through attack of the uridine upon the ωG of the 
substrate resulting in ligation of the flanking sequences. Note the ribozyme product of the 
TES reaction is that ωG (of substrate) remains attached to the 3’-end of the ribozyme. 
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Figure 2.11. Diagram of the ribozyme-mediated trans insertion-splicing reaction. The 
Pneumocystis carinii ribozyme is denoted by gray lines and the TIS donor substrate is 
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Binding 
separated into blue (5’ exon) and red (insert) lines. A blue square within the TIS donor 
substrate denotes a uridine and the red square at the 3’-end denotes a guanosine (ωGi). 
The TIS acceptor substrate is denoted by black lines and the black square denotes a 
uridine. The ribozyme recognition elements; RE1, RE2, and RE3 that form the P1, P9.0, 
and P10 helices are depicted. The TIS donor substrate forms the P1i and P10 helices 
through RE1 and RE3 of the ribozyme. In the first reaction step (substrate cleavage), the 
3’ terminal guanosine (G336) of the ribozyme (open circle at the 3’-end of ribozyme) 
performs a nucleophilic attack upon the 5’ splice site of the TIS donor substrate. This 
results in the covalent attachment of the insert region of the TIS donor substrate to the 3’-
end of the ribozyme. The 5’ exon region of the TIS donor substrate dissociates from the 
ribozyme and the TIS acceptor substrate is bound through a second P1 helix. For the 
second reaction step (substrate cleavage), the ωGi (aligned by P9.0 helix formation) 
performs a nucleophilic attack upon the 5’ splice site in the TIS acceptor substrate. This 
results in the covalent attachment of the 3’ exon region of the TIS acceptor substrate to 
the 3’-end of the ribozyme. The last reaction step (exon ligation) proceeds through the 
nucleophilic attack of the uridine of the 5’ exon region of the TIS acceptor substrate upon 
G336 of the ribozyme, resulting in the final TIS product.  
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CHAPTER THREE-THE GROUP I INTRON-DERIVED RIBOZYME FROM 
PNEUMOCYSTIS CARINII UTILIZES AN ENDOGENOUS GUANOSINE AS 
THE FIRST REACTION STEP NUCLEOPHILE FOR TRANS EXCISION-
SPLICING 
‘Reproduced in part with permission from Biochemistry Copyright 2008 American 
Chemical Society’ 
 
INTRODUCTION 
 
The trans excision-splicing (TES) reaction, catalyzed by a group I intron-derived 
ribozyme from the opportunistic pathogen Pneumocystis carinii (P. carinii), has 
previously been shown to be capable of site-specifically excising targeted sequences from 
within RNA substrates (8). The TES reaction, which is similar to the self-splicing 
reaction, consists of two consecutive transesterification steps whereby the same 
molecular recognition elements employed by other group I intron-derived ribozymes are 
exploited for binding and alignment of subsequent TES substrates. One key difference 
between the reactions, however, is that the self-splicing reaction utilizes an exogenous 
guanosine cofactor as the substrate cleavage nucleophile (3), while TES does not (8).  
In the absence of an exogenous guanosine cofactor, group I intron-derived 
ribozymes can exploit two separate reaction pathways to catalyze the cleavage of their 
intended RNA substrate. These include ribozyme-mediated 5’ hydrolysis or 
intramolecular transesterification (Figure 3.1). It was previously postulated that the P. 
carinii ribozyme could be catalyzing the substrate cleavage reaction through ribozyme-
mediated 5’ hydrolysis (Figure 3.1A) (8). An alternative explanation is that an 
endogenous nucleotide, most likely one at the 3’-end of the ribozyme (Figure 3.1B), is 
the substrate cleavage nucleophile. There is precedent for both reactions (12-17). 
Ribozyme-mediated hydrolysis reactions have previously been shown to occur for other 
group I introns and their derived ribozymes, including the intron-derived ribozyme from 
Tetrahymena thermophila (T. thermophila) (12, 16). The T. thermophila group I intron 
has also been shown to be capable of catalyzing intramolecular cyclization 
(transesterification) reactions utilizing the 3’ terminal guanosine of the intron as an 
intramolecular nucleophile (see Figure 2.1B) (13, 15, 17). 
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To further characterize the TES reaction, the first reaction step (substrate 
cleavage) was investigated by following the accumulation of TES reaction intermediates 
through the course of the reaction. It was found that the substrate cleavage reaction 
proceeds through an intramolecular transesterification reaction pathway and is catalyzed 
by the 3’ terminal guanosine, in this case G336, of the P. carinii (rPC) ribozyme (Figure 
3.2). The intramolecular transesterification reaction pathway is supported by several lines 
of evidence including the observation that the identity of the 3’ terminal nucleotide is 
critical for optimal TES activity and the size and identity of ribozyme reaction 
intermediates isolated from TES reactions (both in vitro and in vivo). Additionally, in 
vivo results demonstrate that the reactive 3’ terminal guanosine can be created through 
self-truncation of the ribozyme transcript, most likely through ribozyme-mediated 3’ 
hydrolysis. Apparently, the ribozyme activates itself for the TES reaction in a cell. The 
implications of these results demonstrate that the ribozyme itself plays a more substantial 
role than previously thought in that the ribozyme itself is an intermediate in the TES 
reaction pathway. 
 
MATERIALS AND METHODS 
 
Oligonucleotide Synthesis and Preparation 
DNA oligonucleotides were obtained from Integrated DNA Technologies 
(Coralville, IA) and were used without further purification. RNA oligonucleotides were 
obtained from Dharmacon Research, Inc. (Lafayette, CO) and were deprotected using the 
manufacturer’s suggested protocol. Concentrations of individual oligonucleotides were 
calculated from UV absorption measurements using a Beckman DU 650 
spectrophotometer (Beckman Coulter, Inc.; Fullerton, CA). RNA oligonucleotides were 
5’-end radiolabeled by phosphorylation of the 5’ terminal hydroxyl group with [γ-32P] 
ATP (Amersham Pharmacia Biotech; Piscataway, NJ) using T4 polynucleotide kinase 
(New England Biolabs; Beverly, MA) as previously described (75). RNA 
oligonucleotides were 3’-end radiolabeled by ligation of 5’-end radiolabeled pCp (5’-
*pCp) to the 3’-end of the RNA oligonucleotide using T4 RNA ligase (New England 
Biolabs) as previously described (10). Note that the 3’-end radiolabeling strategy will 
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result in substrates being a nucleotide longer than 5’-end radiolabeled substrates. 
 
Ribozyme Synthesis and Preparation 
Two ribozymes were constructed via run-off transcription of linearized plasmids. 
For both cases, the P. carinii ribozyme plasmid, PC, was linearized in a 50 μL reaction 
consisting of 16 μg plasmid, 5 μL of 10X REACT 2 buffer (Invitrogen; Grand Island, 
NY), and 50 units of either XbaI (to form PC-X) or HindIII (to form PC-H) at 37 °C for 2 
h. The linearized plasmids were purified using a QIAquick PCR purification kit (Qiagen; 
Valencia, CA).  
Two additional ribozymes were constructed via PCR using the PC plasmid as the 
template. The following primers were used for the individual ribozyme constructs: the 
forward PCR primer for both ribozyme constructs was 
5’CTCTAATACGACTCACTATAGAGGG3’, and the reverse PCR primers (variable 
regions are underlined) for each of the ribozyme constructs were 
5’TTAGATATACTCTTTCTTTCGAAAGAGG3’ for PC-ωA (10), and 
5’CTAGATATACTCTTTCTTTCGAAAGAGG3’ for PC-ωG. All PCR reactions utilized 
45 pmol of each primer in a reaction consisting of 100 ng PC plasmid, 1 unit of Pfu DNA 
polymerase (Stratagene; La Jolla, CA), 1X Pfu reaction buffer (Stratagene), and 0.5 μM 
dNTPs. The PCR conditions were 95 °C for 30 s (initial denaturation), followed by 40 
cycles of 95 °C for 30 s (denaturation), 55 °C for 45 s (annealing), and 68 °C for 120 s 
(elongation). A final elongation step of 68 °C for 360 s was performed after the final 
cycle. PCR products were separated on a 2% agarose gel and were purified using the 
QIAquick Gel Extraction Kit (Qiagen) using the manufacturers protocol.  
Both the linearized and PCR amplified DNA templates were used for run-off 
transcription in a 50 μL reaction consisting of 1 μg DNA template, 50 units of T7 RNA 
polymerase (New England Biolabs), 40 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 5 mM 
DTT, 5 mM spermidine, and 1 mM rNTP mix for 2 h at 37 °C. Each of the individual 
ribozyme constructs were purified using a Qiagen Plasmid Midi Kit (Qiagen), as 
previously described (8). 
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TES Reactions 
TES reactions were conducted at 44 °C in H10Mg buffer consisting of 50 mM 
HEPES (25 mM Na+), 135 mM KCl, and 10 mM MgCl2. Prior to each reaction, 200 nM 
ribozyme in 25 μL H10Mg buffer was preannealed at 60 °C for 5 min and then slow 
cooled to 44 °C. The reaction was initiated by adding 5 μL of a 10 nM solution of 
radiolabeled substrate (also in H10Mg solution). The final concentrations of the ribozyme 
and substrate in the reaction mixtures were 166 nM and 1.3 nM respectively. Time course 
studies were conducted by the periodic removal of 3 μL aliquots, which were then 
quenched by adding an equal volume of 2 X stop buffer (10 M urea, 3 mM EDTA, and 
0.1 X TBE). The products and substrates were denatured at 90 °C for 1 min and then 
separated on a 12.5% denaturing polyacrylamide gel. Gels were dried under vacuum and 
the bands were visualized on a Molecular Dynamics Storm 860 Phosphoimager. The 
observed rate constant, kobs, was obtained from a plot of the percent substrate cleavage 
product (substrate cleavage plus TES product) over time (8). Note the kobs values 
obtained are reported as lower limit values, in some instances, and cannot be taken as 
precise values due to the limits of manual pipetting. 
 
RT-PCR Amplification of TES Reaction Intermediates In Vitro 
TES reactions were conducted using a 20-mer 
(5’AUGACUACUCUCGUGCUCUU3’) substrate using the conditions described above. 
The products were amplified via RT-PCR with the following primers: 
5’GAGGGTCATGAAAGCGGCGTG3’ (specific for the rPC ribozyme) and 
5’GCACCGGTAAGAGCACGAGAG3’ (specific for the bridge-3’ exon). RT-PCR 
reactions were conducted using an Access RT-PCR kit (Promega; Madison, WI) and 
consisted of a 50 μL reaction containing approximately 2 μL TES reaction (166 nM 
ribozyme), 1 mM MgSO4, 45 pmol of each primer, 0.2 mM dNTPs, 5 units AMV reverse 
transcriptase, and 5 units Tfl DNA polymerase. The reactions were subjected to first 
strand synthesis at 45 °C for 45 min, which was followed by 2 min at 94 °C for 
deactivation of the AMV reverse transcriptase. The reactions were then subjected to 40 
PCR cycles consisting of 94 °C for 30 s (denaturation), 55 °C for 60 s (annealing), and 68 
°C for 120 s (elongation). After the cycling was complete, a final elongation step of 68 
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°C for 10 min was performed. The RT-PCR products were separated on a 2% agarose gel 
and excised from the gel matrix using the QIAquick Gel Extraction Kit (Qiagen). The 
excised products were ligated into the pDrive cloning vector (Qiagen) using the 
manufacturer’s recommended protocol and transformed into DH5α cells (Invitrogen). 
Colonies were picked and sequenced for identification (Davis Sequencing; Davis, CA). 
 
 In Vivo Characterization of TES Intermediates 
Plasmids were used that contain both the ribozyme and GFP target transcript. In 
all cases, plasmids were transformed into Escherichia coli (E. coli) strain JM109 (DE3), 
which encodes T7 RNA polymerase, as described (9). Once transformed, T7 RNA 
polymerase was induced by induction with isopropylthiogalactoside (IPTG), which 
resulted in the transcription of both the ribozyme and GFP, as described (9). The 
plasmids: pQBI-Mut-GFP+p3x-RE3 (5) (active ribozyme with mutant GFP) and pQBI-
Mut-GFP+p3x-RE3 (5)-ΔGBS (inactive ribozyme with mutant GFP) were used (9). After 
transformation and induction, 1.5 mL of the designated cell culture was used for total 
RNA isolation using the Ambion RiboPureTM-Bacteria Kit (Ambion; Austin, TX). The 
TES reaction intermediate was amplified via RT-PCR using the following primers: 
5’GTGGAGAGGTAGAAAGCGGCGTG3’ (specific for P. carinii ribozyme) and 
5’CCATGCCATGTGTAATCCCAGCAGC3’ (specific for 3’-end of GFP transcript), 
which amplify products containing only both the ribozyme and the GFP transcript. RT-
PCR reactions were conducted using the Access RT-PCR system (Promega) consisting of 
a 50 μL reaction containing approximately 1 μg total RNA, 1 mM MgSO4, 45 pmol of 
each primer, 0.2 mM dNTPs, 5 units AMV reverse transcriptase, and 5 units Tfl DNA 
polymerase. Reactions were then subjected to first strand synthesis (45 °C for 45 min), 
which was followed by 2 min at 94 °C for deactivation of the AMV reverse transcriptase. 
These reactions were then subjected to 40 PCR cycles consisting of 94 °C for 30 s 
(denaturation), 55 °C for 60 s (annealing), and 68 °C for 120 s (elongation). After the 
cycling was complete a final extension step of 68 °C for 10 min was performed. The RT-
PCR products were separated on a 2% agarose gel and were excised from the gel matrix 
using the QIAquick Gel Extraction Kit (Qiagen). The excised products were ligated into a 
pDrive cloning vector (Qiagen) using the manufacturer’s recommended protocol and 
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transformed into DH5α cells (Invitrogen). Colonies were picked and sequenced (Davis 
Sequencing) for identification. 
 
RESULTS 
 
TES Reaction Intermediates In Vitro 
The two possible substrate cleavage reaction mechanisms, ribozyme-mediated 5’ 
hydrolysis or intramolecular transesterification cleavage, can be distinguished by 
following the reaction intermediates for TES reactions conducted in vitro (Figure 3.1). 
For TES reactions conducted with the substrate, 5’AUGACUGCUC3’, the 5’ hydrolysis 
mediated reaction will result in two reaction intermediates consisting of the 5’-exon 
(5’AUGACU3’) and bridge-3’ exon (5’GCUC3’) (Figure 3.1A). In contrast, the 
intramolecular transesterification reaction will result in two reaction intermediates 
consisting of the 5’-exon (5’AUGACU3’) and the bridge-3’-exon being covalently 
attached to the 3’-end of the rPC ribozyme (5’rPC-GCUC3’) (Figure 3.1B). However, 
there is no size difference between the 5’-exon sequences, which precludes 
discriminating the two cleavage pathways using 5’-end radiolabeled substrate. Using a 
3’-end radiolabeled substrate, however, could potentially distinguish if the bridge-3’-
exon is separate from the ribozyme or if it is being attached to the 3’-end of the ribozyme. 
Therefore, we synthesized the 3’-end radiolabeled substrate (5’AUGACUGCUCC3’ italic 
lettering denotes the nucleotide to be excised and underlined lettering denotes the 
additional nucleotide due to 3’-end radiolabeling) and followed the formation of the 
intermediate and product during the normal course of the TES reaction.  
TES reactions were conducted under previously optimized reaction conditions (8) 
using both 3’ and 5’-end radiolabeled substrates for comparison (Figure 3.3, lanes G-J). 
The results of reaction time course studies (Figures 3.5) show that TES products are 
formed in approximately 70% yield (73 ± 1.8% and 69 ± 3.3%), regardless of which end 
of the substrate is radiolabeled. Because of the limitations of hand mixing relatively fast 
reactions, the only quantification that can be made of observed rate constants, kobs, is a 
lower limit of >8 min-1 for the 3’ labeled substrate (Figure 3.5A) and >6 min-1 for the 5’ 
labeled substrate (Figure 3.5B) for the first step of the TES reaction. More importantly, 
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however, when using 3’-end radiolabeled substrate, essentially all radiolabeled 
intermediate is a high molecular weight band (12 ± 0.3% and 11 ± 1.6%) that 
corresponds to the predicted 341 nucleotide intermediate expected for the intramolecular 
transesterification mechanism. This is not consistent with the hydrolysis mechanism.  
In addition, TES reactions were conducted with the 3’-end radiolabeled substrate, 
10-mer-dG, 5’AUGACUdGCUC3’, which is predicted to prevent the second step of the 
TES reaction (exon ligation) and should accumulate only first step product (Figure 3.4). 
TES reactions conducted with the 10-mer-dG substrate shows that the high molecular 
weight intermediate is now produced in yields of 87 ± 0.4% (Figure 3.5C). This is a 
further indication that the high molecular weight band is the reaction intermediate, and 
suggests that the TES reaction proceeds through the intramolecular transesterification 
mechanism. Again, the only quantification that can be made of the observed rate 
constant, kobs, for the first step of this TES reaction is a lower limit of >6 min-1. 
For confirmation of the identity of TES reaction intermediates, RT-PCR was 
employed to amplify the high molecular weight intermediates for subsequent sequencing 
(Figure 3.6). For these studies a 20-mer substrate, 5’AUGACUACUCUCGUGCUCUU3’, 
was used to facilitate RT-PCR amplification. Our results from sequencing five reaction 
products show that the TES reaction does produce the intermediate expected for the 
intramolecular transesterification reaction, whereby the 3’-end of the substrate 
(5’ACUCUCGUGCUCUU3’) attaches to the terminal nucleotide (G336) of the ribozyme 
(Figure 3.7A). 
 
TES Reactions Using Terminal-Modified Ribozymes 
A defining characteristic of the intramolecular transesterification cleavage 
reaction is that the ribozyme will utilize a terminal guanosine as an intramolecular 
nucleophile and that it must bind to the guanosine-binding site (GBS), which 
preferentially binds guanosine. To test if only guanosine can be utilized as the 
intramolecular nucleophile, PCR templates were used to synthesize two new ribozyme 
constructs, one ending in guanosine (rPC-ωG) and one ending in adenosine (rPC-ωA). If 
only a 3’ terminal guanosine can be used, then only rPC-ωG will be active; rPC-ωA will 
produce neither product nor intermediate. TES reactions were conducted using the same 
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reaction conditions as for the rPC ribozyme (Figure 3.3, lanes K-R). The results show 
that both ribozymes produced intermediate and product with approximately the same 
amount of product being formed (80 ± 1.5% versus 76 ± 2.2%). The terminal adenosine, 
however, results in a slower reaction (kobs = 0.14 ± 0.02 min-1) than that with the terminal 
guanosine (kobs = 2.6 ± 0.09 min-1) (Figure 3.8). Nevertheless, the identity of the 3’ 
terminal end of the ribozyme does affect TES reaction kinetics, as expected only for the 
intramolecular transesterification mechanism. 
 The observation that the rPC-ωA ribozyme produces both intermediate and 
product can be explained through two different scenarios. In the first, the non-encoded 
addition of nucleotides to the 3’-end of RNA transcripts could potentially lead to 
guanosines being added to the 3’-end of the ribozyme, which has previously been shown 
to be a consequence of run-off transcription utilizing T7 RNA polymerase (92, 93). For 
the second, a 3’ terminal adenosine could potentially be used as an intramolecular 
nucleophile. This in fact has previously been demonstrated for a T. thermophila ribozyme 
construct that predominately terminates in an adenosine (94). The RT-PCR strategy 
described above was employed to isolate and sequence the TES ribozyme intermediate 
from TES reactions conducted with rPC-ωA ribozyme. Results show that the terminal 
adenosine is the nucleophile in these reactions (Figure 3.7B). Apparently, the 
intramolecular transesterification reaction can be catalyzed by a terminal guanosine or 
adenosine. That guanosine is ~20-fold more effective (Figure 3.8) is likely related to the 
fact that guanosine is expected to have enhanced affinity for the guanosine binding site 
(GBS) of the ribozyme.  
 
Identification of TES Reaction Intermediates In Vivo 
We have previously shown that TES ribozymes can be used for the excision of 
RNA sequences from within mRNA transcripts utilizing an E. coli model system (9). 
Briefly, a ribozyme was developed to sequence-specifically excise an internal point 
mutation from within a green fluorescent protein (GFP) transcript, thus repairing the 
mutant transcript and creating fluorescent cells (9). It was of interest, therefore, to 
determine if the intramolecular transesterification mechanism is occurring in vivo; and if 
so, how the ribozyme obtains the reactive 3’ terminal nucleotide. To express the GFP-
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specific ribozyme (termed rPC-GFP) in vivo, the ribozyme sequence was flanked by a T7 
RNA polymerase promoter and terminator for proper initiation and termination of 
transcription (95). Although the terminator sequence has previously been shown to 
predominately end in guanosine, shown in Figure (3.9), it was not known if this 
guanosine was acting as an intramolecular nucleophile for the TES reaction (96).  
 TES reactions were conducted in vivo under previously described methods (9). 
Total RNA isolated from in vivo experiments were subjected to RT-PCR reactions using 
primers designed to bind the 5’-end of the rPC-GFP ribozyme and the 3’-end of the GFP 
resulting in the amplification of only the TES reaction intermediate, if present (Figure 
3.10 and 3.11). A single product was amplified by RT-PCR reactions which were ligated 
into a cloning vector and subsequently sequenced for the presence of the TES reaction 
intermediate. Sequence analysis of 17 cloned RT-PCR products showed that the 3’-end of 
the GFP transcript was covalently attached to the 3’-end of the rPC-GFP ribozyme (Table 
3.1). Additionally, in 11 of these cases, the ribozyme was covalently attached to the 
expected site on the target (U607; 5’-UACCUU607-3’) (Table 3.1). However, in 6 of these 
cases, the ribozyme was attached to a similar, but distinct site (U624; 5’-GCCCUU624-3’) 
(Table 3.1). Apparently, the sequence-specificity of this particular ribozyme construct is 
not especially high for cleavage at its intended target. Nevertheless, finding the TES 
ribozyme intermediate strongly suggests that the intramolecular transesterification 
mechanism also occurs in vivo.  
Surprisingly, in 16 of the 17 cases the T7 terminator sequence was not present at 
the 3’-end of the ribozyme (Figure 3.9), which suggests that it was somehow removed in 
vivo prior to the ribozyme becoming functional (Table 3.1). For the other case, a small 
portion of the T7 terminator sequence was present at the 3’-end of the ribozyme. In 16 
sequences the active ribozyme ended with the natural terminal nucleotide of the ribozyme 
(G336), and in 1 case it ended with a guanosine 4 bases downstream (G340) (Figure 3.9). 
It is likely that these terminal guanosines are being created through a ribozyme-mediated 
intramolecular 3’ hydrolysis reaction, which is well known to occur in vitro (13, 15, 17, 
68, 69, 97). If true, the ribozyme is catalyzing its own activation prior to catalyzing the 
TES reaction. Taken together, these results strongly support a mechanism where a 
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ribozyme 3’ terminal guanosine is the substrate cleavage nucleophile in the TES reaction, 
both in vitro and in vivo. 
 
3’ Hydrolysis Can Activate the Ribozyme for the Intramolecular Transesterification 
Reaction 
In order to test whether TES ribozymes can generate 3’ terminal guanosines via 3’ 
hydrolysis, the TES and RT-PCR procedures were conducted in vitro using a ribozyme 
construct containing an elongated 3’-end. The ribozyme, termed rPC-HindIII was created 
by linearizing the PC plasmid with HindIII (instead of XbaI), which linearizes the 
plasmid seven bases downstream of G336. TES reactions conducted in vitro using 5’ and 
3’-end radiolabeled 10-mer substrates resulted in the formation of the expected 
intermediates and products (Figure 3.3, lanes S-V), showing the construct is still active 
even though it was synthesized to be longer than necessary. Sequence analysis (total of 
five sequences) of the TES ribozyme intermediate showed that the expected 
intramolecular transesterification intermediate is found, including that it ends in G336. 
Apparently, the extra seven bases were removed in vitro, thus activating G336 for 
subsequent TES reactivity, as expected.  
 
DISCUSSION 
 
TES Reaction Mechanism 
In this study, it was determined that the identity of the 3’ terminal nucleotide of 
the P. carinii ribozyme is important for effective catalysis of the substrate cleavage 
reaction in TES reactions; that a 3’ guanosine is required for this reactivity; that substrate 
cleavage is not significantly driven by ribozyme-mediated hydrolysis; that the 3’ half of 
the target transcript is covalently attached to the 3’ terminal guanosine of the ribozyme in 
the intermediate step of the TES reaction; and that this mechanism is occurring in vitro 
and in vivo. These results are compiled into the reaction mechanism shown in Figure 3.1.  
These results suggest the following reaction mechanism for the first step of the 
TES reaction. First, the ribozyme binds the target transcript via the RE1 molecular 
recognition component, resulting in the formation of helix P1. The site of first step 
37 
reactivity (substrate cleavage) is thus determined as the 3’-end of helix P1, usually 
characterized by a G•U wobble base-pair (48, 49). The 3’ terminal guanosine (in this 
case G336) appears to bind to the catalytic core of the ribozyme via the GBS, hence the 
preference for a 3’ terminal guanosine, aided presumably by P9.0 helix formation. This 
conformationally orients the 3’ hydroxyl group of the ribozyme for nucleophilic attack at 
the phosphodiester backbone of the substrate cleavage site. The result of this substrate 
cleavage reaction step is that the 3’ half of the target transcript becomes covalently 
attached to the ribozyme. Concurrently, the 5’ half of the target transcript remains bound 
to the ribozyme through secondary and tertiary interactions via helix P1.  
The second reaction step of the TES reaction, called exon-ligation, is catalyzed by 
the free 3’ hydroxyl group in helix P1, which is typically a uridine (48, 49). This 
nucleophile attacks the phosphodiester backbone upstream and adjacent to the target 
transcript guanosine now in the GBS, resulting in the formation of a normal 
phosphodiester bond between the regions flanking the excised segment. As occurs in self-
splicing (46, 47, 59), a local conformation change in the ribozyme occurs, prior to exon 
ligation, which results in the sequential rearrangement of guanosines in the GBS. The 3’ 
terminal guanosine of the ribozyme is replaced by the 3’ guanosine of the target’s excised 
segment. The overall reaction, then, has the excised segment being removed from the 
target transcript. 
 
TES Reaction In Vivo 
The results demonstrate that the intramolecular transesterification cleavage 
mechanism is also occurring when the TES reaction takes place in E. coli. Sequencing of 
reaction products indicate that the same reaction intermediates are generated in vivo as in 
vitro. Moreover, it was discovered that, in a cell, the ribozyme becomes truncated at its 
3’-end, resulting in the creation of an active 3’ terminal guanosine at the 3’-end of the 
ribozyme (Figure 3.9). It is likely that this truncation is catalyzed by the ribozyme itself, 
and that the mechanism is site-specific 3’ hydrolysis (13, 15, 17, 68, 69, 97). In addition, 
sequencing of TES reaction intermediates demonstrates that the ribozyme targets two 
similar sites on the GFP transcript (out of hundreds of possible sites), with the desired site 
being targeted 65% of the time. Previous studies using the P. carinii ribozyme have 
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shown that stable base-pairing between the substrate and the first four nucleotides of the 
ribozymes RE1 region (to form a functional P1 helix) is primarily responsible for the 
molecular recognition components that bind the substrate to the ribozyme (98). It is not 
surprising, then, to find that both the major and minor target sites are able to form this 
four nucleotide helix, which accounts for their similar reactivities. Taken together, the in 
vivo reaction demonstrates that the TES is following an intramolecular transesterification 
cleavage mechanism, the ribozyme is self-activating, and the reaction is only moderately 
sequence-specific. 
 
The 3’ Terminal Adenosine Ribozyme and Role of Molecular Recognition 
Results demonstrate that the P. carinii ribozyme can utilize a 3’ terminal 
adenosine (A336) as the intramolecular transesterification nucleophile. Presumably, the 
terminal adenosine binds to the GBS of the ribozyme, which is known to preferentially 
bind guanosine (57). Studies using a T. thermophila ribozyme, however, suggest that 
adenosine can bind the GBS with the help of non GBS interactions (94). The most likely 
interaction is the formation of helix P9.0 (Figure 3.1B), which participates in the 
alignment of the 3’ splice site of group I introns into the GBS (60-66). It seems for the 
TES reaction, the role of P9.0 helix formation could be multifaceted in that it helps to 
align the terminal nucleotide of the ribozyme into the GBS prior to the intramolecular 
transesterification reaction, and also aligns the substrate guanosine (the guanosine to be 
excised) into the GBS for the subsequent exon-ligation reaction (Figure 3.1B). 
 
Comparison with Previous Results 
That the 3’ terminal guanosine of group I intron-derived ribozymes can be a 
nucleophile has previously been reported, although not in the context of the TES reaction. 
The terminal guanosine of the T. thermophila group I intron-derived ribozyme has been 
implicated in ribonuclease (15), phosphotransferase (13), and phosphatase (13) activities 
in vitro. In these reactions, the ribozymes 3’ terminal guanosine was obtained through 
site-specific 3’ hydrolysis, which exploited high temperature ribozyme pre-incubations 
under alkaline conditions (15, 17, 68, 69). We found that production of active rPC 
ribozyme in vitro does not require this pre-incubation, although 3’ hydrolysis might still 
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be occurring, albeit at prevailing reaction conditions. The T. thermophila intron also 
utilizes a 3’ terminal guanosine for catalyzing the reverse splicing reaction (79, 80), in 
which the intron becomes imbedded into cellular transcripts as well as in vitro cyclization 
reactions (67-70). Other group I ribozymes have exploited their 3’ terminal guanosines 
for polymerization (76, 77) and recombination (78) reactions. Apparently, 3’ terminal 
guanosines of group I intron-derived ribozymes can be involved in many natural and 
unnatural reactions. 
Group I intron-derived ribozymes have additionally been exploited for catalyzing 
reactions where a 3’ terminal guanosine is not required. In these instances, an exogenous 
guanosine cofactor is usually the first (or only) reaction step nucleophile. For example, 
group I intron-derived ribozymes have been used to replace terminal (81-90) segments of 
RNA transcripts, resulting in the repair of mutant transcripts. Apparently, group I intron-
derived ribozymes can catalyze a wide variety of reactions, which demonstrates their 
versatility in both catalysis and molecular recognition. 
 
Design Principles for the P. carinii Ribozyme In Vivo 
Synthesizing RNAs that contain specific terminal sequences is challenging 
because RNA polymerases tend to add non-templated nucleotides onto the ends of RNA 
transcripts (92, 93). One common strategy is to use a small self-cleaving ribozyme to 
truncate the elongated target transcript at the desired site (72, 99). Unfortunately, this 
method is invasive and creates a 2’, 3’ cyclic phosphate, which would eliminate TES 
reactivity, though the 2’, 3’ cyclic phosphate could subsequently be removed by 
dephosphorylation to render the active form of the ribozyme. Fortunately, at least in E. 
coli (and confirmed in vitro), TES ribozymes appear to self-catalyze their own truncation, 
thus creating a functional 3’ terminal guanosine. The efficiency with which the 3’ 
hydrolysis reaction occurs with the rPC ribozyme, however, has not yet been determined 
in vivo. This might be a limiting factor for TES reaction conducted in vivo. If true, 
enhancing the 3’ hydrolysis reaction could enhance the yield of TES ribozymes. To this 
end, it has been reported that P10 helix formation prior to the first step of the self-splicing 
reaction increases the amount of 3’ hydrolysis product obtained in vitro (100). This 
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design strategy could be implemented by adding sequences after G336 that are 
complementary to RE3 of the ribozyme (see Figure 3.1).  
In this study it was demonstrated that the ribozyme is not entirely specific for the 
intended site on the target. This lack of absolute sequence-specificity was found to be 
true with other group I intron-derived ribozyme-mediated reactions (82). Therefore, a 
variety of strategies has been devised to ameliorate this limitation. Chief among them is a 
clever strategy to add an artificial substrate binding element to a trans-splicing ribozyme 
(83, 84, 86-90). This extended guide sequence (EGS) could easily be inserted at the 5’-
end of the ribozyme to help increase sequence specificity of TES ribozymes.  
Prior to this study, no reasonable experimental strategies could be used to 
determine sites within an RNA transcript that are accessible to the rPC ribozyme. Our 
results, however, suggest that accessible sites can be determined by amplifying the 
intermediates using RT-PCR. Intermediates will only be formed if their target sites are 
accessible. This strategy could be implemented by using one primer that is specific for 
the ribozyme and the other primer can be specific for the 3’-end of the transcript.  
 
Implications for Native Group I Intron Function In Vivo 
Group I introns catalyze the self-splicing reaction, wherein the introns excise 
themselves (sometimes with the requirement of proteins), from RNA transcripts. It has 
also been demonstrated that intact group I introns can be mobile elements by catalyzing a 
reverse-splicing reaction (79, 80). We now demonstrate that essentially intact group I 
introns can covalently attach themselves to RNA transcripts in trans while catalyzing the 
removal of an internal segment from within RNA transcripts through TES. Apparently, 
group I introns are multifaceted in vivo catalysts. 
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Table 3. 1. Analysis of ribozyme intermediates isolated from in vivo testing from JM109(DE3) cells 
 
 
Test construct 
 
RT-PCR 
producta
 
TES intermediate 
utilizing G336b
 
TES 
intermediate 
utilizing G340c
 
Primary site 
targetedd
 
Alternative 
site 
targetede 
  
Active ribozyme 
+ Mutant GFP 
+ 
 
94% 
 
6% 
 
65% 
 
35% 
a Total RNA isolated from JM109 (DE3) cells were subjected to RT-PCR to amplify the ribozyme 
intermediate with the 3’-end of the GFP mRNA attached to the ribozyme; (+) positive RT-PCR band. 
b Percentage of ribozyme intermediates with 3’-end of GFP mRNA attached through G336 of the 
GFP-rPC ribozyme (16 of 17 RT-PCR products sequenced). c Percentage of ribozyme intermediates 
with 3’-end of GFP mRNA attached through G340 of the GFP-rPC ribozyme (1 of 17 RT-PCR 
products sequenced). d Percentage of RT-PCR products sequenced (11 of 17 RT-PCR products) that 
indicated the GFP-rPC ribozyme targeted the primary site (U607, Codon 201). e Percentage of RT-
PCR products sequenced (6 of 17 RT-PCR products) that indicated the GFP-rPC ribozyme targeted 
an alternative site (U624, Codon 207).   
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Figure 3.1. Comparison of potential TES reaction mechanisms. The P. carinii ribozyme 
is shown as a grey line and the 5’ and 3’ exons are black lines. The bridge region (the 
region to be excised) is shown as a dashed gray line. The black square within the 5’ exon 
represents a uridine and the gray circle adjacent to the 3’ exon represents a guanosine. 
The open circle (B) at the 3’-end of the ribozyme represents the 3’ terminal nucleotide of 
the ribozyme (ωG or ωA). The first step of the TES reaction proceeds through either 
ribozyme-mediated 5’ hydrolysis (A) or ribozyme-mediated intramolecular 
transesterification (B). 
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Figure 3.2. Proposed secondary structure of the Pneumocystis carinii (rPC) ribozyme. 
The rPC ribozyme is denoted in uppercase lettering. The molecular recognition elements 
are denoted in bold uppercase. The potential 3’ terminal guanosine, G336, of the 
ribozyme is in bold lettering. 
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Figure 3.3. Representative polyacrylamide gel for TES conducted with 5’ and 3’-end 
radiolabeled substrates. Polyacrylamide gel showing the substrates, intermediates, and 
products of TES reactions conducted with 166 nM ribozyme and 1.33 nM substrate at 44 
°C for 15 min. Lanes A, C, and E contain 5’-end radiolabeled 10-mer, 9-mer, and 6-mer 
size controls. Lanes B, D, and F contain 3’-end radiolabeled 10-mer, 9-mer, and 5-mer 
size controls. Note that the 3’-end radiolabeled size controls are one nucleotide larger 
than 5’-end radiolabeled size controls. Gel lanes containing a plus (+) sign show reactions 
conducted in H10Mg and lanes containing a minus (-) sign show reactions conducted in 
H0Mg. Lanes G-J contain the normal rPC ribozyme with 5’-end radiolabeled 10-mer 
(lanes G and H) or 3’-end radiolabeled 10-mer (lanes I and J). Lanes K-N contain the 
rPC-ωA ribozyme with 5’-end radiolabeled 10-mer (lanes K and L) or 3’-end 
radiolabeled 10-mer (lanes M and N). Lanes O-R contain the rPC-ωG ribozyme with 5’-
end radiolabeled 10-mer (lanes O and P) or 3’-end radiolabeled 10-mer (lanes Q and R). 
Lanes S-V contain the rPC-HindIII ribozyme with 5’-end radiolabeled 10-mer (lanes S 
and T) or 3’-end radiolabeled 10-mer (lanes U and V). 
 
45 
 
 
 
Ribozyme Intermediate
11-mer
10-mer 
5-mer 
Size
Controls 
G A B C D E F 
- + +-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. Representative polyacrylamide gel for TES reactions conducted with the 10-
mer-dG substrate. Polyacrylamide gel showing TES substrate, intermediate, and product 
of TES reactions conducted with 166 nM ribozyme, 1.33 nM substrate, H10Mg, at 44 °C 
for 15 min. Lanes A, B, and C contain 3’-end radiolabeled 11-mer, 10-mer, and 5-mer 
size controls, respectively. Note that 3’-end radiolabeled size controls are one nucleotide 
larger than 5’-end radiolabeled size controls. Plus (+) represent TES reactions conducted 
in H10Mg and minus (-) represent TES reactions conducted in H0Mg (Lane D) or 
without ribozyme (Lane E). Lane F contained the normal rPC ribozyme with 3’-end 
radiolabeled 10-mer. Lane G contains the normal rPC ribozyme with the 3’-end 
radiolabeled 10-mer-dG substrate. 
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Figure 3.5. Graphical representations of TES reactions as a function of substrate. 
Reactions were conducted in duplicate with 166 nM rPC, 1.33 nM substrate, and H10Mg 
at 44 °C for 15 min. A. TES reaction using 5’-end radiolabeled substrate 
(AUGACUGCUCC).  The 10-mer TES product (kobs >6 min-1) is represented by filled 
circles, and the higher molecular weight (ribozyme) intermediate is represented by open 
circles. B. TES reaction using 3’-end radiolabeled substrate (AUGACUGCUC). The 9-
mer TES product (kobs >8 min-1) is represented by filled circles and the 6-mer 
intermediate is represented as open circles. C. TES reaction using 3’-end radiolabeled 
substrate (AUGACUdGCUCC).  The 10-mer TES product is represented by filled circles, 
and the higher molecular weight (ribozyme) intermediate (kobs >6 min-1) is represented by 
open circles. Each graph shows the average of two independent assays. Standard 
deviations for each time point are less than 15%. 
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Figure 3.6. Diagram of RT-PCR strategy for the amplification of TES ribozyme 
intermediate. TES reactions conducted with rPC and rPC variants using the 20-mer TES 
substrate (5’AUGACUACUCUCGUGCUCUU3’). Reaction with the substrate will result 
in the covalent attachment of the bridge-3’ exon region (5’ACUCUCGUGCUCUU3’, 
denoted as grey block) to the 3’-end of the rPC ribozyme. The bridge-3’ exon region is 
used as a primer binding site for reverse transcription (RT) for first strand synthesis of the 
TES ribozyme intermediate. An additional primer, specific for the 5’-end of the rPC 
ribozyme, is included for the polymerase chain reaction (PCR) to amplify the TES 
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ribozyme intermediate, if present. Isolated RT-PCR products are subsequently ligated 
into a cloning vector and sequenced for identification of TES ribozyme intermediates. 
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Figure 3.7. Sequencing results for RT-PCR products isolated from TES ribozyme 
intermediates. A. Representative chromatogram for sequencing result for the rPC 
ribozyme. Note that the 3’-end of the substrate attaches to the terminal nucleotide (G336) 
of the ribozyme. Individual nucleotides are denoted by color; guanosine (black), 
adenosine (green), cytosine (blue), and thymine (red). B. Representative chromatogram 
for sequencing result for the rPC-ωA ribozyme. The 3’ terminal nucleotide (A336) is 
depicted in green. Note that the 3’-end of the substrate attaches to the terminal nucleotide 
(A336) of the ribozyme.  C. Table summarizing all five sequencing results for the rPC 
and rPC-ωA ribozymes. 
 
 
 
 
 
 
 A G336 A C T T T T T TC C G   G  C C A A336 A C C C G  G  C CT T  T T T T
Table 1.  Sequencing results for RT-PCR products isolated from TES reactions conducted with rPC and rPC-
A B 
C 
ωA ribozymes. 
Ribozyme Number of sequences 
(RT-PCR products) 
Identity of 3’ terminal 
nucleotidea 
Sequence of ribozyme+ bridge-
3’exonb 
rPC 5 G336 5’AG336ACUCUCGUGCUCUU3’ 
rPC-ωA 5 A336 5’AA336ACUCUCGUGCUCUU3’ 
a RT-PCR products were isolated from TES reactions conducted with either the rPC or rPC-A ribozyme 
construct. Sequencing demonstrated that the 3’ terminal nucleotide was either a guanosine (G336 for rPC) or 
adenosine (A336 for rPC-ωA). b Sequencing of 5 RT-PCR products demonstrated that the bridge-3’ exon 
region of the 20-mer substrate (5’AUGACUACUCUCGUGCUCUU3’) became covalently attached to the 3’ 
terminal nucleotide of each ribozyme. 
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Figure 3.8. Graphical representations of TES reactions as a function of ribozyme 
construct. Reactions were conducted in duplicate with 166 nM ribozyme, 1.33 nM 
substrate, and H10Mg at 44 °C for 15 min. A. TES reaction using the PCR-derived rPC-
ωA ribozyme construct. The 10-mer TES product (kobs = 0.14 ± 0.02 min-1) is represented 
by filled circles, and the higher molecular weight (ribozyme) intermediate is represented 
by open circles. B. TES reaction using the PCR-derived rPC-ωG ribozyme construct. The 
10-mer TES product (kobs = 2.6 ± 0.09 min-1) is represented by filled circles, and the 
higher molecular weight (ribozyme) intermediate is represented by open circles. Each 
graph shows the average of two independent assays. Standard deviations for each time 
point are less than 15%. 
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Figure 3.9. Sequence and proposed secondary structure of the rPC-GFP ribozyme. The 
previously constructed rPC-GFP ribozyme (8) designed for in vivo model test system is 
shown in uppercase lettering. The sequence and predicted structure of the T7 terminator, 
which was appended onto the 3’-end of the rPC-GFP ribozyme for in vivo experiments 
are highlighted. The guanosines (G336 and G340) found to act as ribozyme 3’ terminal 
guanosines are denoted. 
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Figure 3.10. RT-PCR strategy for isolation of the TES intermediate in vivo. The 
endogenous guanosine-mediated 5’ cleavage reaction in vivo will result in the covalent 
attachment of the 3’-end of the GFP mRNA to the 3’-end of the P. carinii ribozyme 
(GFP-rPC) through a 3’ terminal guanosine. The TES ribozyme intermediate, if present, 
will constitute a portion of the total RNA isolated from JM109 (DE3) cells (Step 1). In 
step 2, the 3’-end of the GFP transcript is used as a primer binding site for reverse 
transcription (RT) for first strand synthesis of the TES ribozyme intermediate. An 
additional primer, specific for the 5’-end of the GFP-rPC ribozyme, is used for 
polymerase chain reaction (PCR) in step 3 to amplify the TES ribozyme intermediate. 
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Isolated RT-PCR products are subsequently ligated into a cloning vector (Step 4) and 
sequenced for identification of TES ribozyme intermediates. 
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5’AUGgcuagcaaaggagaagaacucuucacuggaguugucccaauucuuguugaauuagaugg
ugauguuaacggccacaaguucucugucaguggagagggugaaggugaugcaacauacggaaaac
uuacccugaaguucaucugcacuacuggcaaacugccuguuccauggccaacacuagucacuacuc
ugugcuaugguguucaaugcuuuucaagauacccggaucauaugaaacggcaugacuuuuucaag
agugccaugcccgaagguuauguacaggaaaggaccaucuucuucaaagaugacggcaacuacaag
acacgugcugaagucaaguuugaaggugauacccuuguuaauagaaucgaguuaaaagguauuga
cuucaaggaagauggcaacauucugggacacaaauuggaauacaacuauaacucacacaauguaua
caucauggcagacaaacaaaagaauggaaucaaagugaacuucaagacccgccacaacauugaagau
ggaagcguucaacuagcagaccauuaucaacaaaauacuccaauuggcgauggcccuguccuuuua 
 
 
ccagacaaccauUACCUU607GUCCACacaaucugcccuuucgaaagaucccaacgaaaag 
 
 
agagaccacaugguccuucuugaguuuguaacagcugcugggauuacacauggcauggaugaacu
guacaacUGA7203’ 
Start 
P1 helix 
P10 helix 
5’ splice site 
Stop 
A 
B  
5’GUGGAGAGGUAgaaagcggcgugaaaacguuagcuagugaucuggaa 
 
 
uaaauucagauugcgacacugucaaauugcggggaagcccuaaagauucaacuacu
aagcaguuuguggaaacacagcuguggccgaguuaauagcccuggguauaguaac
aauguugaauaugaaucuuuugcgagaugaaaugggugauccgcagccaaguccu
aagggcauuuuugucuauggaugcaguucaacgacuagauggcaguggguauug
uaaggaauugcaguuuucuugcagugcuuaagguauagucuauccucuuucgaaa
 
gaaagaguauaucuaG3383’ 
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RE3 RE1 
5’GUGGAGAGGUAgaaagcggcgugaaaacguuagcuagugaucuggaauaaauucagauugc 
 
 
gacacugucaaauugcggggaagcccuaaagauucaacuacuaagcaguuuguggaaacacagcugugg
ccgaguuaauagcccuggguauaguaacaauguugaauaugaaucuuuugcgagaugaaaugggugauc
cgcagccaaguccuaagggcauuuuugucuauggaugcaguucaacgacuagauggcaguggguauug
uaaggaauugcaguuuucuugcagugcuuaagguauagucuauccucuuucgaaagaaagaguauau 
 
 
cuaG338-GUCCACacaaucugcccuuucgaaagaucccaacgaaaagagagaccacaugguccuuc 
 
 
uugaguuuguaacagcugcugggauuacacauggcauggaugaacuguacaacuga4533’ 
 
 
Upstream primer binding site 
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3’ Terminus of rPC-GFP 
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Figure 3.11. Sequences of predicted RNA transcripts for isolation of in vivo TES 
ribozyme intermediate. A. Sequence of the coding region of the GFP mRNA transcript 
(720 nt). The nucleotides involved in P1 and P10 helix formation are denoted in bold, 
black lettering. The region to be excised is denoted in bold, red lettering. The 5’ splice 
site is denoted with an arrow. B. Sequence of the rPC-GFP ribozyme. The molecular 
recognition elements RE1 and RE3 and the 3’ terminal guanosine (G338) are denoted in 
bold, black lettering. Note that the rPC-GFP ribozyme is two nucleotides longer than the 
normal rPC ribozyme due to RE3 consisting of five nucleotides. C. Sequence of the 
predicted in vivo TES ribozyme intermediate. The TES ribozyme product will consist of 
the 3’-end of the GFP transcript being covalently attached to the 3’-end of the rPC-GFP 
ribozyme. The TES ribozyme intermediate is predicted to be 453 nt in length. The 
upstream and downstream primer binding sites utilized for the RT-PCR strategy are 
underlined. 
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CHAPTER FOUR-KINETIC CHARACTERIZATION OF THE FIRST STEP OF 
THE RIBOZYME-CATALYZED TRANS EXCISION-SPLICING REACTION 
 
INTRODUCTION 
 
As previously discussed, a group I intron-derived ribozyme from Pneumocystis 
carinii can catalyze the excision of a targeted sequence from within an RNA substrate 
(8). The reaction, termed trans excision-splicing (TES), consists of two reaction steps; 
substrate cleavage (intramolecular transesterification) followed by exon ligation (Figure 
4.1). In the substrate cleavage reaction, the phosphodiester backbone of TES substrates 
are cleaved through nucleophilic attack of a 3’ terminal guanosine (G336), generating 
both 5’ and 3’ exon intermediates (see Chapter 3). In the exon-ligation step, a 
nucleophilic uridine (at the 3’-end of the 5’ exon intermediate) performs a nucleophilic 
attack upon a phosphodiester backbone position within the 3’ exon intermediate, resulting 
in ligation of the exon sequences and excision of the internal segment (Figure 4.1). The 
substrate cleavage reaction step is analogous to that in self-splicing (3), except that self-
splicing utilizes an intermolecular nucleophile (exogenous guanosine), while the TES 
reaction utilizes an intramolecular nucleophile (endogenous guanosine). The TES 
substrate cleavage reaction is similar to the cyclization reactions performed by group I 
introns for generating both full-length and truncated circular introns (67-70, 101). 
The establishment of kinetic frameworks has been useful for the dissection of the 
individual steps of RNA catalyzed reactions (16, 72, 73, 102-111). The results obtained 
from these types of studies have been mechanistically informative and have advanced our 
fundamental understanding of the chemical basis for RNA catalysis. To further 
investigate the fine details regarding the mechanism of the TES substrate cleavage 
reaction, a minimal kinetic framework for the substrate cleavage reaction was established 
(Figure 4.2). 
There are several conclusions drawn from this kinetic framework as they relate to 
the TES reaction. The rate constant for the substrate cleavage reaction is approximately 
60-fold lower than that reported for the self-splicing reaction using a Tetrahymena 
thermophila ribozyme, regardless of whether an intermolecular or intramolecular 
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guanosine is being utilized as the substrate cleavage nucleophile (16, 17). The rate 
constant for substrate dissociation is only 4-fold lower than that for substrate cleavage. In 
addition, product dissociation is slower than the rate of cleavage which suggests that 
multiple turnover, with respect to substrate cleavage, will likely be curtailed. The results 
indicate that a conformational change exists between the two steps of the TES reaction. 
Taken together, these results have greatly increased our current understanding of the 
mechanism for the TES reaction. The kinetic framework presented herein will likely lead 
to developing TES ribozymes that are more efficient at catalyzing the TES reaction either 
in vitro or in vivo. 
 
MATERIALS AND METHODS 
 
Oligonucleotide Synthesis and Purification 
RNA oligonucleotides were obtained from Dharmacon Research, Inc. (Lafayette, 
CO) and were deprotected using the manufacturer’s standard protocol. Oligonucleotide 
concentrations were calculated from UV absorption measurements using a Beckman DU 
650 spectrophotometer (Beckman Coulter, Inc.; Fullerton, CA). Oligonucleotides were 
5’-end radiolabeled via phosphorylation of the 5’ terminal hydroxyl group with [γ-32P] 
ATP (Amersham Pharmacia Biotech; Piscataway, NJ) using T4 polynucleotide kinase 
(New England Biolabs; Beverly, MA), as previously described (75). 
 
Ribozyme Synthesis 
The Pneumocystis carinii ribozyme plasmid, PC, was linearized in a 50 μL 
reaction consisting of 16 μg of plasmid, 1 X REACT 2 buffer, and 50 units XbaI 
(Invitrogen; Grand Island, NY) at 37 °C for 2 h. The linearized plasmid was isolated 
using the QIAquick PCR purification kit (Qiagen; Valencia, CA). Run-off transcription 
was performed for 2 h in a 50 μL reaction consisting of 1 μg of linear DNA, 50 units of 
T7 RNA polymerase (New England Biolabs), 40 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 
5 mM DTT, 5 mM spermidine, and 1 mM rNTP mix. The individual ribozyme were 
purified by a Qiagen Plasmid Midi Kit as previously described (8). 
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Determination of Observed Substrate Cleavage Rate Constants (kobs and k2) 
The first order rate constant for substrate cleavage, kobs, was measured under 
single-turnover conditions, in which case the release of product would not affect the 
observed rate constants. All reactions were conducted at 44 °C in H10Mg buffer, which 
consists of 50 mM HEPES (25 mM Na+), 135 mM KCl, and 10 mM MgCl2 at pH 7.5. 
These reaction conditions appear to be optimal for the TES reaction (8). For the pH 
dependence studies, HEPES (pH 7.5) was replaced with MES (pH 5.0 - 6.8), HEPES (pH 
6.8 - 7.5), or EPPS (pH 7.5 - 8.5). Reactions were initiated by adding 5 µL of an 8 nM 
solution of 5’-end radiolabeled substrate [r(5’AUGACUdGCUC3’)] in the appropriate 
buffer to a 25 µL solution of various concentrations of ribozyme (6 nM-360 nM) in the 
same buffer. Note that the ribozyme solution was preincubated at 60 °C for 5 minutes and 
then allowed to slow cool to 44 °C)  to facilitate folding of the ribozyme prior to the 
addition of the radiolabeled substrate. Aliquots (3 μL) were removed at specified times 
and quenched with an equal volume of 2x stop buffer (10 mM urea, 0.1x TBE, 3 mM 
EDTA). The substrate and products were denatured at 90 °C for 1 min and then separated 
on a 12.5% denaturing polyacrylamide gel. The bands were visualized on a Molecular 
Dynamics Storm 860 Phosphorimager and quantified using Imagequant software 
(Molecular Dynamics). Data were fit using the Kaleidagraph curve-fitting program 
(Synergy Software; Reading, PA). The final concentration of the radiolabeled substrate in 
all reactions is 1.3 nM. A typical reaction utilized H10Mg buffer and a final ribozyme 
concentration of 166 nM. Pseudo-first order rate constants for the appearance of products 
were fit using the following single exponential equation: 
[P]t = [P]∞(1-e-kt)   [1] 
In this equation [P]t and [P]∞ are the percentages of product formed at time t and at the 
end point, respectively; and k is the first order rate constant. 
  
Determination of the Substrate Dissociation Rate Constant (k-1) 
Pulse-chase experiments (16, 112) were used to measure the rate constant for 
substrate dissociation, k-1. In these experiments, 10 µL of 200 nM ribozyme in H10Mg 
buffer was combined with 2 µL of 8 nM 5’ radiolabeled substrate in H10Mg buffer for a 
period of t1 = 30 s. The ribozyme solution was preincubated at 60 °C for 5 min and then 
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slow cooled to 44 °C before the addition of the substrate, which was also at 44 °C. The 
chase phase was then initiated by taking out 5 µL of the reaction mixture and diluting the 
reaction mixture with 25 µL of H10Mg buffer so that [E] < KM. During the chase period, 
t2, dissociation of labeled substrate from the ribozyme is essentially irreversible. Aliquots 
were removed at various times during the chase phase and the reaction was quenched by 
adding an equal volume of 2X stop buffer. An otherwise identical reaction, but without 
adding the chase (which in this case is buffer), was carried out in parallel. The first-order 
observed rate constants kobs, chase and kobs, no-chase were obtained from a single-
exponential fit of this data using Equation 1 (as a function of t2). The observed rate 
constant for substrate dissociation (k-1) was then calculated (Equation 2) as the difference 
between the two measured observed rate constants: 
k-1  = kobs, chase -  kobs, no-chase    [2] 
 
Determination of the Substrate Association Rate Constant (k1) 
The rate constant for substrate binding, k1, was measured using a series of pulse-
chase experiments. In each reaction, 5 µL of a ribozyme stock (from 36 to 240 nM) in 
H10Mg buffer was combined with 1 µL 8 nM 5’-end labeled substrate and allowed to 
react in a total volume of 6 µL. For each ribozyme concentration, several chase reactions 
were initiated. In each chase, 1 µL of the original reaction mixture was removed and 
diluted five-fold at various times, t1, ranging from 15 s to 120 s. The addition of chase 
renders the dissociation of the substrate essentially irreversible. The chase reaction, t2, 
was then allowed to proceed for 15 min, at which point the 5’ cleavage reaction was 
essentially complete. The reaction was quenched with an equal volume of 2X stop buffer. 
The percent product formed during the chase period was plotted against time t1. Observed 
rate constants (kobs) were obtained by fitting the data to Equation 1. This observed rate 
constant measures the rate of approach to equilibrium where substrate association is equal 
to substrate dissociation. Hence, the rate of substrate association was obtained (16, 108) 
by plotting kobs against ribozyme concentration and fitting to the equation:  
kobs = k1 [E] + k-1 
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Determination of the Dissociation Constant of the Ribozyme-Product Complex, ( KdP)  
The equilibrium dissociation constant KdP of the 5’ exon mimic binding to the 
ribozyme was determined using native polyacrylamide gel electrophoresis (75, 98, 103, 
107). In this assay, several concentrations of ribozyme, ranging from 1.5 nM to 300 nM, 
were preannealed in 5 μL total volume containing 3.4% glycerol and H10Mg buffer for 5 
min at 60 °C. After the solutions slow cooled to 44 °C, 2.5 µL of a stock of 0.5 nM 
radiolabeled 5’ exon mimic in H10Mg buffer at 44 °C was added. The mixture was 
incubated at 44 °C for at least 90 min. To maintain the integrity of the bound species 
during gel electrophoresis, the gel and the running buffer was made of H10Mg buffer and 
they were prewarmed to 44 °C before the samples were loaded. The bound and unbound 
5’ exon mimics were separated from each other by running 6 µL of each reaction on a 
10% nondenaturing polyacrylamide gel. The gel was placed on chromatography paper 
(Whatman 3MM CHR) and dried under vacuum for 30 min at 70 °C. The bands were 
visualized on a Molecular Dynamics Storm 860 Phosphorimager. The bands were 
quantified using ImageQuant software (Molecular Dynamics). Data were fit with 
Kaleidagraph curve-fitting program (Synergy Software) using the equation:   
θ = [ribozyme]u /([ribozyme]u + Kd) 
In this equation, Kd is the equilibrium dissociation constant of the 5’ exon mimic, 
θ is the fraction of 5’ exon mimic bound to the ribozyme, and [ribozyme]u is the 
concentration of unbound ribozyme in the reaction (75, 113). 
 
Determination of Rate Constant of Sustrate Cleavage Product Dissociation (k-3) 
The dissociation rate constant of the 5’ exon intermediate (k-3), was measured by a 
pulse-chase protocol, followed by analysis of the ribozyme/product complex using native 
polyacrylamide gel electrophoresis. In a typical experiment to measure k-3, A solution of 
300 nM ribozyme in 10 μL H10Mg buffer containing 3.4% glycerol was preincubated for 
5 min at 60 °C and then allowed to slow cool to 44 °C. Then 5 µL of 0.5 nM 5’-end 
labeled 5’ exon intermediate was added and the reaction mixture was incubated at 44 °C 
for 30 min to allow complete binding. A chase reaction was then initiated by the addition 
of 40 µL of 5.4 μM unlabeled 5’ exon intermediate (in reaction buffer) to follow the 
dissociation of 5’ exon intermediate from the ribozyme-5’ exon complex. The final 
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concentrations of the reactants in the chase reaction were 40 nM ribozyme, 33 pmol 5’-
end labeled substrate cleavage product, and 4 μM unlabeled 5’ exon intermediate (as 
chase) in 50 µL reaction volume. Time points were taken by removing 5 μL aliquot from 
the reaction mixture and immediately loaded onto a running 10% native polyacrylamide 
gel. The dissociation rate was obtained using equation 1. Additionally, the rate constant 
of substrate cleavage product association (k3) was obtained (111) using the equation:   
k3 = k-3/KdP. 
 
RESULTS 
 
A kinetic scheme for the substrate cleavage reaction is summarized in Figure 4.2. 
One complication in studying the substrate cleavage reaction step, however, is that the 
second reaction step of TES (exon ligation) proceeds immediately after the first step (19). 
Therefore, a previously described modified substrate system [r(5’AUGACUdGCUC3’)] 
that contains a deoxyguanosine at the site of excision has been shown to prevent the 
second reaction step of TES (see Chapter 3, Figure 3.4). To test the ability of this new 
deoxyguanosine substrate to undergo the substrate cleavage reaction, it was allowed to 
react with the ribozyme under optimized TES reaction conditions (8). We found that the 
deoxyguanosine substrate (kobs value of 3 ± 0.5 min-1) only minimally reduces the 
observed rate constant of the substrate cleavage reaction as compared to the normal 
substrate (kobs value of 3.7 ± 0.2 min-1). Therefore, the deoxyguanosine substrate 
reasonably mimics the normal substrate as a first reaction step substrate. Importantly, this 
substrate inhibits the exon-ligation step, allowing us to isolate and analyze only the first 
reaction step. 
 
Observed Rate Constants for Substrate Cleavage, kobs and k2 
Ribozyme excess conditions were used to determine the pseudo-first-order rate 
constant for the substrate cleavage reaction. Note that under these reaction conditions the 
ribozyme-product complex is denatured upon addition of stop buffer, and so product 
dissociation is not observable. Therefore, these experiments measure the rate of substrate 
cleavage from the ribozyme-substrate complex.  
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The observed rate constants (kobs) were measured in reactions containing various 
ribozyme concentrations (5-300 nM) and 1.3 nM of 5’-end radiolabeled substrate 
(Figures 4.3A and 4.3B). As seen in Figure 4.3C, the observed rate constants at the higher 
ribozyme concentrations (100-350 nM) are independent of ribozyme concentration. This 
indicates that saturation of the ribozyme has been reached. A value of k2 = 4.1 ± 0.5 min-1 
and KM = 102 ± 0.4 nM were obtained by fitting the average kobs values to the Michaelis-
Menten equation. Herein, k2 represents the maximum first order rate of substrate cleavage 
under single turnover conditions. For lower ribozyme concentrations, 5-40 nM, the kobs 
values for the substrate cleavage reaction increase linearly with ribozyme concentration. 
This linear dependence reflects the apparent second order rate constant, k2/KM, and the 
slope gives a value of (2.8 ± 0.5) x 107 M-1 min-1 (Figure 4.3D). Note the values obtained 
are similar to values previously reported for other group I intron-derived ribozymes (72, 
73, 114). 
 
Dependence of Substrate Cleavage on pH 
It has been reported that the rate of substrate cleavage step in Tetrahymena (16), 
Anabaena (72), and Azoarcus (73) group I introns, as well as reaction steps for some 
small ribozymes (115-117), show a log-linear increase in the reaction rate constant with 
increasing pH in the acid range (up to pH 7). This is consistent with a single 
deprotonation step that activates the cleavage nucleophile, prior to the substrate cleavage 
reaction (118). This is also consistent with the observed rate constant at a given pH being 
equivalent to the rate constant of the chemical step at that pH. This was investigated for 
the Pneumocystis ribozyme by measuring the pH dependence of the observed rate 
constant of the substrate cleavage reaction. As seen in Figure 4.4, the logarithm of the 
observed rate constant increases linearly with pH in the range of 5 to 7 (slope = 0.5 ± 
0.03), but not at higher pH values. In the case of the Tetrahymena group I intron-derived 
ribozyme, such non-linear behavior was attributed to a pH-dependent conformational 
change occurring within the ribozyme (119, 120). This conformational change thus sets a 
limit on the observed rate constant of cleavage (k2), even though the rate constant of 
chemistry (kc) is expected to continue to increase with increasing pH (119, 120). 
Apparently, for our substrate cleavage reaction, the rate of the chemical step is potentially 
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being masked by a similar conformational change, and so k2 is not equivalent to kc. The 
rate of chemistry (kc), however, can be approximated by extrapolating the log-linear 
increase that occurs between pH of 5 and 7 to higher pH values. In our case, kc is then 
approximately equal to 5.7 ± 1.1 min-1 at pH 7.5 (Figure 4.4). 
Control experiments were run to determine whether the observed rate constants 
shown in Figure 4.4 were being influenced by the specific buffers utilized in the 
respective reactions. We found that the values obtained using MES and HEPES at pH 6.8 
were within standard deviation of each other. This was also true using HEPES and EPPS 
at pH 7.5. Apparently, there is not a buffer-specific effect on the observed rate constants 
(kobs). Note that we have not examined the rates of substrate cleavage outside the pH 
range depicted because protonation or deprotonation of nucleotides is expected to cause 
general chemical denaturation of the ribozyme (121).  
 
Rate Constant for Substrate Dissociation, k-1 
The upper limit of the rate constant for substrate dissociation was measured in a 
pulse-chase experiment. In this experiment, the time chosen for t1 (30 s) was such that a 
significant fraction of the substrate would remain unreacted. After the addition of the 
chase, which in this case is dilution with buffer, aliquots were removed at designated 
times up to 15 min. An otherwise identical reaction, but without the added chase, was 
carried out in parallel. The observed rate constants for the chase reaction (kobs, chase = 2.5 
± 0.04 min-1) and in the reaction without added chase (kobs, no-chase = 1.5 ± 0.01 min-1) 
were obtained from a single-exponential fit of product formation against t2 (Figure 4.5). 
The substrate dissociation rate constant (k-1 = 0.9 ± 0.04 min-1) was then determined 
using Equation 2 (see Materials and Methods). Note that k-1 is comparable in value to the 
cleavage step (k2), implying that the ribozyme-substrate complex does not reach 
equilibrium with free ribozyme prior to the cleavage step.  
 
Rate Constant for Substrate Association, k1 
The kinetic data indicates that substrate dissociation is comparable in value to the 
cleavage step. This implies that the second-order rate constant, k2/KM, will be a 
combination of substrate association (k1), dissociation (k-1) and cleavage (k2) steps. Thus, 
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the second-order rate constant can be represented as k2/KM = k1k2/(k-1 + k2) (122). As 
discussed earlier, a value of 2.8 x 107 M-1 min-1 was obtained for the second order rate 
constant k2/KM. Using this value of k2/KM and the values of k2 and k-1 (4.1 min-1 and 0.9 
min-1 respectively), the calculated value of k1 is 3.4 x 107 M-1 min-1.  
For confirmation, k1 was directly measured in a pulse-chase experiment. In this 
case, ribozyme and radiolabeled substrate were combined for varying times, tl (15 s to 
120 s), and then chased with excess buffer to prevent further binding. The mixtures were 
then incubated for a time t2 = 15 min, which ensures that essentially every substrate 
molecule that binds to the ribozyme during tl is converted to product. The amount of 
product formed was plotted against time t1 (Figure 4.6). The kobs values reflect the rate of 
approach to equilibrium of the ribozyme-substrate complex formation, which is 
represented by kobs = k1 [E] + k-1. The slope of the plot of kobs versus ribozyme 
concentration gives the rate of substrate association, kl = (1 ± 0.01) x 107 M-1 min-l 
(Figure 4.6), which is in reasonable agreement (for ribozyme reactions) with the 
calculated value above.  
 
Reversibility of the Substrate Cleavage Reaction 
Under single turnover conditions, the first order rate constant (k2) of the substrate 
cleavage reaction is 4.1 min-1 (Figure 4.3), with a typical end point of 70-80%. Over the 
time period of 15 to 60 min, this end point does not change, indicating that either an 
internal equilibrium exists between ribozyme-substrate and ribozyme-product complexes 
or only 70-80% of the substrate is reactive. Such an internal equilibrium has previously 
been identified in a guanosine-dependent substrate cleavage reaction catalyzed by a 
Tetrahymena group I intron-derived ribozyme (17). Therefore, a pulse-chase experiment 
was conducted such that this equilibrium, if occurring, could be disturbed and thus 
detected (17). In this assay, the substrate cleavage reaction was allowed to proceed to 
completion and then an excess of unlabeled 5’ exon mimic was added. The addition of a 
large excess of unlabeled 5’ exon mimic is expected to prevent rebinding of any 
dissociated radiolabeled substrate or radiolabeled 5’ exon reaction product. The result 
(Figure 4.7) shows that a substantial fraction of the bound radiolabeled product can be 
converted back to radiolabeled substrate, hence an internal equilibrium exists. 
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Furthermore, the results imply that product dissociation is slower than or similar to 
substrate dissociation (17).  
 
Equilibrium Dissociation Constant of the Substrate Cleavage Product, KdP, and 
Substrate, KdS 
A trace amount of 5’-end labeled substrate cleavage product (the 6-mer) was 
incubated with various concentrations of ribozyme for 90 min at 44 °C in H10Mg buffer, 
and the ribozyme-product complex was then partitioned from the unbound product on a 
native polyacrylamide gel (75, 113). The equilibrium dissociation constant of the 5’ exon 
product (KdP = 69 ± 6 nM) was then determined from a plot (Figure 4.8) of the fraction 
product bound versus ribozyme concentration (75, 113).  
The equilibrium dissociation constant of the substrate, KdS, is not directly 
measurable because the substrate cleavage reaction occurs before the binding equilibrium 
is established. An estimated value of the equilibrium dissociation constant of the 
substrate can be obtained, however, from the equation KdS = (k-1 /k1) = 90 nM.  
 
Rate Constant for Dissociation of the 5’ Exon Product, k-3 
The product dissociation rate constant (k-3) was determined using a pulse-chase 
assay, combined with native polyacrylamide gel electrophoresis. In this assay, an excess 
of ribozyme was mixed with 1.3 nM 5’-end labeled 5’ exon mimic, which was then 
incubated in H10Mg buffer containing 3.4 % glycerol at 44 °C for 30 min. An excess 
amount of unlabeled 5’ product was then added to initiate the chase, and aliquots were 
removed at designated times. These aliquots were directly loaded onto a running native 
polyacrylamide gel to isolate the bound and unbound fractions. For quantification, the 
amount of product not bound after the chase was subtracted from that at time t1, which 
yields the amount of product dissociated due to the chase. The rate of product 
dissociation (k-3 = 0.09 ± 0.05 min-1) was then obtained from fitting Equation 1 to a single 
exponential function (Figure 4.9). Apparently, product dissociation is slower than 
substrate dissociation, which show that the substrate cleavage reaction is not an effective 
multiple turnover reaction. 
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DISCUSSION 
 
The Pneumocystis carinii ribozyme catalyzes the excision of internal segment 
from within an RNA substrate (see Figure 4.1). The first reaction step (substrate 
cleavage) is catalyzed by the 3’ terminal guanosine (G336) of the Pneumocystis ribozyme 
(see Chapter 3) and is similar to the cyclization reactions catalyzed by group I introns for 
the creation of both full-length (FLC) and truncated circular group I introns (67-70, 101). 
To further enhance our current understanding of the mechanism of the substrate cleavage 
reaction; a minimal kinetic scheme was developed for the individual steps of the substrate 
cleavage reaction. The use of a deoxyribose-containing substrate allowed the isolation of 
the first reaction step (substrate cleavage) while disallowing the second reaction step 
(exon ligation). Note, however, that in the context of the full TES reaction, the substrate 
cleavage product is actually an intermediate, between the two reaction steps. 
 
Substrate Binding 
The rate constant for the substrate binding the Pneumocystis ribozyme, k1, is far 
below the diffusional limit of 1011 M-1 min-1 for the collision of small molecules (123). 
Thus, unlike classical enzymes which react near diffusion-controlled limits (122, 124-
126), the Pneumocystis ribozyme is not under diffusion control.  This value, however, is 
within the range (107 - 109 M-1 min-1) expected for the formation of RNA duplexes (127-
131), as seen with other ribozymes (16, 103, 108, 110, 111, 132). Thus, the rate of 
assembly of the Pneumocystis ribozyme-substrate complex appears to be limited by the 
process of helix formation. Nevertheless, because k2/KM (k2 = 4.1 min-1 and KM = 102 nM 
respectively) approaches the rate of substrate association, catalysis can be expected to 
occur about as fast as base pairing between the ribozyme and substrate. This is typical of 
ribozymes that bind their substrates through double helices (16, 108, 109, 111, 133). Of 
equal importance is that the on-rate of the substrate, k1, is 7 orders of magnitude faster 
than the off rate, k-1. Therefore, the substrate is relatively slow to dissociate from the 
ribozyme once bound.  
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Substrate Cleavage 
The rate constant for the substrate cleavage reaction, k2, under single turnover 
conditions was determined to be 4.1 min-1. Though it appears that the true rate constant 
for the actual chemical step is being masked, probably by a local conformational change 
that occurs after substrate binding and before the actual chemical step, this rate is 
approximately four times faster than the rate constant for substrate dissociation (k-1 = 0.9 
min-1). Although the substrate is more likely to react than it is to dissociate, the similar 
order of magnitude suggests that a non-trivial fraction of the substrate will dissociate 
before the substrate cleavage reaction occurs.  
The ‘catalytic power’ of an RNA-cleaving ribozyme can be estimated by 
comparing the observed rate constant of a catalyzed reaction to that of an equivalent 
uncatalyzed reaction. Under simulated physiological conditions, the uncatalyzed rate 
constant of the phosphotransesterification reaction (knoncat) is estimated to be 10-9 min-1 
(16, 134). Thus, a rate of 4.1 min-1 for the substrate cleavage reaction represents a 
catalytic rate enhancement (k2/knoncat) of approximately 109-fold. This rate enhancement 
also corresponds to approximately 13 kcal/mol of transition-state stabilization according 
to the following equation: ∆G° = -RT ln (k2/knoncat), as discussed (16).  
It was previously reported that a Tetrahymena ribozyme can also catalyze a 3’ 
terminal guanosine-mediated substrate cleavage reaction (13, 15, 17, 68), albeit under 
different optimized conditions using different substrates. In one such study (17), the 3’ 
terminal guanosine catalyzed reaction was reported to behave similar to the exogenous 
guanosine catalyzed reaction, for which kc = 350 min-1 (16). In comparison, the 
Pneumocystis endogenous reaction is approximately 60-fold slower (kc = 5.7 min-1). This 
substantial difference might be due to the Tetrahymena ribozyme being faster than the 
Pneumocystis ribozyme, the difference in reaction conditions, or that the endogenous 
guanosine nucleophile in the Pneumocystis ribozyme, although bound to the GBS, is not 
bound in an ideal orientation. Indeed, this last idea could be supported in that proper 
alignment of the endogenous guanosine nucleophile with respect to the Pneumocystis 
ribozyme could be hindered by the absence of a P9.0 helix interaction, which is predicted 
to align the intramolecular guanosine into the GBS (17). Although more detailed studies 
using the same reaction conditions and sequences would have to be conducted in order to 
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make these comparisons more concrete, it is apparent that the intramolecular guanosine-
mediated substrate cleavage reaction is substantially slower than either intermolecular or 
intramolecular guanosine-mediated substrate cleavage reaction for the case of the 
Tetrahymena ribozyme. 
Furthermore, the observed rate constant of substrate cleavage shows pH 
independence between pH 7 and 8.5 implying that at this range the rate of chemistry 
associated with substrate cleavage is masked by a conformational change (119, 120). The 
simplest interpretation of this result is that the rate of substrate cleavage is not equivalent 
to the rate of chemistry, and that the rate of chemistry (extrapolated to be kc = 5.7 min-1) 
is faster than the rate of substrate cleavage (measured to be k2 = 4.1 min-1). 
 
Product Dissociation 
For the fraction of substrates that do undergo the reaction, the resultant products 
dissociate from the ribozyme relatively slowly on the time scale of the reaction. 
Furthermore, dissociation of the 5’ exon product is slower than the cleavage step (by 
about 45-fold), which significantly impedes the ribozyme from catalyzing multiple 
turnover reactions. Of course, the 5’ exon product of the cleavage reaction is an 
intermediate in the complete TES reaction, and so slow product dissociation is beneficial 
for the TES reaction as a whole. In addition, the product off-rate, k-3, is 20-fold slower 
than the substrate off-rate, k-1. Apparently, there are additional or more stable interactions 
that the ribozyme uses to bind the product relative to the ribozyme binding the substrate. 
This is perhaps due to destabilization of substrate binding via positioning of the 3’ 
bridging phosphoryl oxygen at the cleavage site next to a required Mg ion in the ground 
state (135). As negative charge develops on the 3’ oxygen upon entering the transition 
state, this interaction will become more favorable. This transition state stabilization is 
thought to be an important stabilization/destabilization factor in ribozyme-substrate 
binding (135). 
 
A Conformation Change Exists Between the Two Steps of the TES Reaction 
The substrate guanosine to be excised (G1) and its 2’-OH group are required for 
the second step of TES (18), similar to (if not the same as) the role of the ωG in the 
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second step of self-splicing (57, 63, 136-141). This suggests that the G1 is likely binding 
to the GBS of the ribozyme prior to the exon-ligation step of TES. In the substrate 
cleavage step, however, the 3’ terminal guanosine (G336) of the ribozyme (Figure 4.1) is 
binding to that same GBS. Therefore, for the TES reaction, there is likely a local 
conformational change between the two reaction steps that sees the G1 displace the 
ribozymes 3’ terminal guanosine for binding into the GBS (Figure 4.1). That there exists 
a conformational change is further supported by kinetic data that shows that for the 
substrate cleavage reaction, substrate dissociation is faster than product dissociation 
(Figure 4.2), implying that different (strengths of) interactions hold the substrate and the 
5’ exon cleavage product. The local conformational change that occurs in TES is likely 
similar to the local conformational change that occurs in self-splicing, with the 
displacement of the exogenous guanosine by the ωG of the intron (3, 46, 47, 59). 
Nevertheless, as TES uses an intramolecular nucleophile and self-splicing uses an 
intermolecular nucleophile, the local conformational changes between the two steps of 
each reaction are likely not identical.  
 
Implications for TES applications 
TES substrates, once bound, are four times more likely to undergo the substrate 
cleavage reaction as they are to dissociate. Therefore, to make more effective TES 
ribozymes, one could decrease the rate of substrate dissociation relative to that for the 
substrate cleavage reaction. Potential strategies for achieving this are to increase the 
strength of helix P1, either through target selection or elongation of helix P1. Note, 
however, that this strategy could result in a decrease in the rate of substrate cleavage.  
The results also suggest that the Pneumocystis ribozyme catalyzes the substrate 
cleavage reaction (catalyzed by either an exogenous or endogenous guanosine) 
approximately 60-fold slower than the Tetrahymena ribozyme. These results suggest that 
the rate of the substrate cleavage reaction could be improved upon by decreasing the rate 
of substrate dissociation before the cleavage step.  
 
 
Copyright © Perry Patrick Dotson II 2008 
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Figure 4.1. Schematic of the two-step TES reaction. The rPC ribozyme is in uppercase 
lettering and, the 10-mer substrate is in lowercase lettering, and the ribozyme recognition 
elements RE1 and RE3 base pair with the substrate to form helices P1 and P10, 
respectively. The sites of catalysis for the first step (substrate cleavage) and the second 
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step (exon ligation) are shown with arrows, and the guanosine to be excised (G1) is 
circled. The diagram shows only the recognition elements of the ribozyme. 
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E E●*S
k2 = 4.1 min-1
E●P
k1 = 1x107 M-1 min-1
k-1 = 0.9 min-1
k-3 = 0.09 min-1
k3 = 3.5 x 107 M-1min-1
E + P
KdP = 69 nMKdS = 90 nM kc = 5.7 min-1 
 
 
 
 
 
 
 
 
 
Figure 4.2. Kinetic scheme for the substrate cleavage reaction. E denotes the rPC 
ribozyme, S denotes the 10-mer substrate, and P denotes the 6-mer cleavage product. All 
rate and equilibrium constant values were measured or calculated (boxed values) in this 
report. The scheme includes rate constants for substrate association (k1) and dissociation 
(k-1), cleavage (k2), and product association (k3) and dissociation (k-3). Note that the 
observed rate constant for the cleavage step (k2) is distinguishable from the actual rate 
constant for chemistry (kc). The scheme also includes equilibrium constants for substrate 
(KdS) and product (KdP) dissociation. 
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Figure 4.3. Substrate cleavage reactions. All reactions were conducted in H10Mg buffer. 
(A) Representative polyacrylamide gel with the 5’-end labeled substrate and 166 nM rPC 
ribozyme. The positions of the substrate and the substrate cleavage product on the gel are 
labeled. The lane marked (+) buffer contains a 15 min reaction in the absence of the 
ribozyme. (B) Representative plot of the substrate cleavage reaction at 5 nM (▲), 10 nM 
(○), 20 nM (□), 40 nM (◊), 166 nM (∆), and 300 nM (●) ribozyme concentration. All data 
points between the two independent assays have a standard deviation less than 15%. (C) 
Fit of the average kobs values from panel B versus ribozyme concentration (0-350 nM) to 
the Michaelis-Menten equation. The plot resulted in a value of k2 = 4.1 ± 0.5 min-1 and 
KM = 102 ± 0.4 nM respectively. These values are the average of the two independent 
assays. D. Linear fit of the average kobs values from panel B versus ribozyme 
concentration (5-40 nM). The resulting k2/KM value (2.8 ± 0.5 x 107 M-1 min-1) is the 
average of the two independent assays.  
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Figure 4.4. pH dependence of the observed rate of substrate cleavage. Values for were 
obtained from single turnover reactions at 44 °C using 166 nM ribozyme, 1.3 nM 5’-end 
labeled substrate in buffer containing 135 mM KCl and 10 mM MgCl2. The buffers used 
for this study were 50 mM MES (pH 5.0-6.8), 50 mM HEPES (pH 7.0, 7.5), or 50 mM 
EPPS (pH 8.0, 8.5). Each rate is the average of two independent measurements and has a 
standard deviation less than 15%. The solid line represents the log-linear increase in the 
data set from pH of 5 to 7 (slope = 0.5 ± 0.03). The extrapolation of the line to pH 7.5 
(depicted by dashed lines) gives a value of 0.75 ± 0.1 which corresponds to rate of 
chemistry (kc) of 5.7 ± 1.1 min-1.   
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Figure 4.5. Determination of the rate constant for substrate dissociation, k-1. (A) Scheme 
of the pulse-chase experiment, which was conducted in H10Mg buffer at 44 °C and 166 
nM ribozyme. The chase was initiated by diluting the reaction mixture with H10Mg 
buffer. (B) Representative plot of cleaved substrate, after t1, versus time (t2) with chase 
(closed circles) and without added chase (open circles). The resultant first order rate 
constants obtained with the chase (kobs, chase = 2.5 ± 0.04) and without the chase (kobs, no-
chase = 1.5 ± 0.01 min-1) are the average of two independent assays. All data points 
between the two independent assays have a standard deviation less than 10%. From this 
data, the rate of substrate dissociation, k-1, is 0.9 ± 0.04 min-1. 
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Figure 4.6. Determination of the rate constant for substrate association, k1. (A) 
Representative plot of pulse-chase experiments in H10Mg buffer at 44 °C with five 
different ribozyme concentrations: 30 nM (○), 50 nM (▲), 100 nM (◊), 150 nM (♦), and 
200 nM (●). All data points between the two independent assays have a standard 
deviation less than 10%. (B) Representative plot of the kobs values against ribozyme 
concentration. The line is fit to the equation kobs = k1[E] + k-1 and the substrate association 
rate (k1 = 1 ± 0.01 x 107 M-1 min-l) was calculated from the slope. Note that the error bars 
present on the graph are too small to be seen.  
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Figure 4.7. Substrate cleavage products undergo the reverse reaction. A plot of the 
disappearance of substrate in a normal reaction (no chase, closed circles) and 
reappearance of the substrate in the presence of chase (open circles). Each point on the 
plot is the average of two independent experiments, and has a standard deviation less than 
10%. Note that the error bars present on the graph are too small to be seen.  
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Figure 4.8. Determination of the equilibrium dissociation constant of the substrate 
cleavage product, KdP. In the reaction, various concentrations of ribozyme were mixed 
with trace amounts of 5’-end radiolabeled substrate cleavage product in H10Mg buffer 
containing 3.4 % glycerol. Shown is a representative plot of the percent substrate 
cleavage product bound to the ribozyme versus ribozyme concentration. The resultant 
value of KdP is 69 ± 6 nM is the average of two independent assays with each data point 
having a standard deviation less than 15%. 
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Figure 4.9. Determination of the rate constant for dissociation of the 5’ exon product, k-3. 
Representative plot of the fraction of unbound product versus chase time, t2. The rate of 
product dissociation, k-3, is 0.09 ± 0.05 min-1, which is the average of two independent 
assays with each data point having a standard deviation typically less than 20%. 
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CHAPTER FIVE- THE TRANS EXCISION-SPLICING REACTION CAN BE 
CATALYZED BY GROUP I INTRON-DERIVED RIBOZYMES FROM 
TETRAHYMENA THERMOPHILA AND CANDIDA ALBICANS 
 
INTRODUCTION 
 
Group I intron-derived ribozymes, which are essentially exon-less introns, have 
previously been shown to catalyze non-native reactions that are similar to the self-
splicing reaction (3, 6). In one such reaction, termed trans excision-splicing (TES), an 
intron-derived ribozyme from Pneumocystis carinii catalyzes the excision of an internal 
segment from within an RNA substrate, resulting in the reattachment of the flanking 
regions (Figure 5.1) (8). The TES reaction, which is similar to other ribozyme-mediated 
reactions, proceeds through two consecutive transesterification reactions: substrate 
cleavage followed by exon ligation (Figure 1). For the substrate cleavage reaction, the 3’ 
terminal guanosine of the Pneumocystis ribozyme catalyzes the intramolecular cleavage 
of TES substrates (Figure 5.1) (see Chapter 3). Substrate cleavage is followed by exon 
ligation, resulting in formation of the final TES products (Figure 5.1).  
In general, group I intron-derived ribozymes contain all the structural elements 
required for catalyzing the TES reaction. This suggests that group I intron-derived 
ribozymes other than P. carinii could catalyze the TES reaction. Therefore, intron-
derived ribozymes from Tetrahymena thermophila and Candida albicans were 
constructed and tested for their ability to catalyze TES reactions, using as substrates their 
own native 5’ and 3’ exon sequences (Figure 5.2) (71, 74). 
In this study, the Tetrahymena and Candida ribozymes were shown to catalyze 
the excision of a single nucleotide from within their ribozyme-specific substrates. 
Furthermore, both ribozymes were shown to catalyze substrate cleavage through 
intramolecular transesterification, similar to the Pneumocystis ribozyme. The overall 
yield of TES reactions, however, differed between the individual ribozyme constructs. 
The Tetrahymena and Candida ribozyme constructs were shown to catalyze the 
individual steps of TES less efficiently (~20% lower yields) than the Pneumocystis 
ribozyme. This variation appears to be due to the individual ribozymes ability to 
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productively utilize their 3’ terminal guanosine as the intramolecular nucleophile. 
Overall, however, the results demonstrate TES is a general ribozyme-mediated reaction. 
 
MATERIALS AND METHODS 
 
Oligonucleotide Synthesis and Preparation 
DNA oligonucleotides were obtained from Integrated DNA Technologies 
(Coralville, IA) and were used without further purification. RNA oligonucleotides were 
obtained from Dharmacon Research, Inc. (Lafayette, CO) and were deprotected using the 
manufacturer’s suggested protocol. Concentrations of individual oligonucleotides were 
calculated from UV absorption measurements using a Beckman DU 650 
spectrophotometer (Beckman Coulter, Inc.; Fullerton, CA). RNA oligonucleotides were 
5’-end radiolabeled by phosphorylation of the 5’ terminal hydroxyl group with [γ-32P] 
ATP (Amersham Pharmacia Biotech; Piscataway, NJ) using T4 polynucleotide kinase 
(New England Biolabs; Beverly, MA) as previously described (75). RNA 
oligonucleotides were 3’-end radiolabeled by ligation of radiolabeled pCp (5’-*pCp) to 
the 3’-end of the RNA oligonucleotide using T4 RNA ligase (New England Biolabs), as 
previously described (10). Note that 3’-end radiolabeling results in substrates being one 
nucleotide longer than 5’-end radiolabeled substrates. 
 
Plasmid Construction 
For these studies, two ribozyme constructs were created: pT-X, derived from the 
plasmid pT7L-21 (kindly provided by Douglas H. Turner, University of Rochester; 
Rochester, NY) which contains the Tetrahymena ribozyme (71), and pC, derived from 
the plasmid pC10/1x (provided by Douglas H. Turner) that contains the Candida 
ribozyme (74). The individual ribozyme sequences were modified to include an RE3 
sequence so that a P10 helix interaction would form upon binding substrate (see Figure 
5.2).  
The plasmids, pT and pC, were made by changing the parental plasmids, pT7L-21 
and pC10/1x, via site directed mutagenesis. The pT plasmid was created using a single 
round of site directed mutagenesis using the primer pairs (underlined bases represent 
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inserted nucleotides) 5’CGACTCACTATAGACCTTTGGAGGGAAAAG3’ and 
5’CTTTTCCCTCCAAAGGTCTATAGTGAGTCG3’ for RE3 formation. The pC plasmid 
was created using a single round of site-directed mutagenesis using the primer pairs 
5’CGACTCACTATAGGTAAGGGAGGCAAAAGTAGGG3’ and 
5’CCCTACTTTTGCCTCCCTTACCTATAGTGAGTCG3’ for RE3 formation. Note that 
a guanosine was inserted at the 5’-end of the each ribozyme construct to ensure efficient 
transcription by T7 RNA polymerase (92).  
Additionally, an XbaI restriction site was inserted at the 3’-end of the pT plasmid, 
which creates a terminal guanosine (required for the intramolecular transesterification 
reaction), as well as making the 3’-ends of all the ribozymes the same (see Chapter 3). 
The plasmid, pT-X, was created in two rounds using the following primer pairs 
(underlined bases represent changes to the 3’-end of the ribozyme) 
5’GGAGTACTCGATAAGGTAGCCAAATGCC3’ and 
5’GGCATTTGGCTACCTTATCGAGTACTCC3’ for the first round. The primer pairs 
5’GGAGTACTCTAGATAAGGTAGCCAAATGCC3’ and 
5’GGCATTTGGCTACCTTATCTAGAGTACTCC3’ were used for the second round. 
Each set of primers (22.5 pmol for each primer) was used in an amplification 
reaction consisting of 25 ng parental plasmid (pT7L-21, pT, or pC10/1x), 2.5 units Pfu 
DNA polymerase (Stratagene; La Jolla, CA), and 0.5 mM dNTPs (Invitrogen; Grand 
Island, NY) in a buffer consisting of 10 mM KCl, 10 mM (NH4)2SO4, 20 mM Tris-HCl 
(pH 8.8), 2 mM MgSO4, 0.1% Triton X-100, and 0.1 mg/mL BSA (total reaction volume 
is 50 μL). After an initial denaturation for 30 s at 95 °C, the mixture was subjected to 20 
cycles of 95 °C for 30 s, 50 °C for 2 min, and 68 °C for 6 min. Parental plasmid was then 
digested with 20 units DpnI (New England Biolabs) in 4.1 μL of the manufacturer’s 
supplied buffer (10X NEBuffer 4) for 2 h at 37 °C. A 3 μL aliquot of this mixture was 
then used to transform Escherichia coli DH5α competent cells (Gibco BRL). The vectors 
were purified using a QIAprep Spin Miniprep Kit (QIAGEN; Valencia, CA), and were 
sequenced for confirmation of the individual changes (Davis Sequencing; Davis, 
California). 
 
 
83 
Ribozyme Synthesis and Purification 
The Pneumocystis plasmid (PC) (8), the Tetrahymena plasmid (pT-X), and the 
Candida plasmid (pC) were linearized in a 50 μL reaction consisting of 16 μg plasmid, 5 
µL 10X REACT 2, and  50 U of XbaI (Invitrogen; Grand Island, NY). The reactions were 
incubated at 37 °C for 2 h followed by purification using a QIAquick PCR purification 
kit (Qiagen) using the manufacturers suggested protocol. The resulting linearized 
plasmids were subjected to run-off transcription reactions in a 50 μL volume consisting 
of 1 μg DNA template, 50 U of T7 RNA polymerase (New England Biolabs), 40 mM 
Tris-HCl (pH 7.5), 10 mM MgCl2, 5 mM DTT, 5 mM spermidine, and 1 mM rNTP mix. 
The reactions were incubated at 37 °C for 2 h, at which time each ribozyme construct was 
purified using a Qiagen Plasmid Midi Kit (Qiagen), as previously described (8). 
Concentrations of individual ribozymes were calculated from UV absorption 
measurements using a Beckman DU 650 spectrophotometer (Beckman Coulter, Inc.) 
using the previously reported extinction coefficient of 3.5 x 106 M-1 cm-1 for the 
Pneumocystis (rPC) ribozyme (75), 3.2 x 106 M-1 cm-1 for the Tetrahymena (rT-X) 
ribozyme (71), and 3.72 x 106 M-1 cm-1 for the Candida (rC) ribozyme (74). 
 
TES Reactions 
Reactions were performed at 44 °C in buffer consisting of 50 mM Hepes (25 mM 
Na+), 135 mM KCl, and various concentrations of MgCl2. TES reactions were optimized 
for magnesium concentration (0-35 mM MgCl2), ribozyme concentration (0-500 nM), 
and time (1-45 min). In each case, TES reaction conditions were optimized to give the 
greatest TES product yield. Briefly, a ribozyme solution, in HXMg buffer, lacking 
substrate was preannealed at 60 °C for 5 min, and then slow cooled to 44 °C. Reactions 
were initiated by the addition of 1 μL of 8 nM 5’-end radiolabeled substrate (10-mer, 
5’AUGACUGCUC3’ for rPC; 13-mer, 5’CUCUCUGAAAGGU3’ for rT-X; or 11-mer, 
5’GACUCUGCUUA3’ for rC). Note that the italic lettering in the substrates represent the 
nucleotide to be excised. The final concentration of the substrates in the reaction mixtures 
was 1.3 nM. For mechanistic studies, 3’-end radiolabeled substrates were employed at the 
same concentrations stated above. Reactions were conducted at 44 °C for the optimized 
amount of time, and stopped by adding an equal volume of stop buffer (10 M urea, 3 mM 
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EDTA, and 0.1X TBE). Reactions were denatured for 1 min at 90 °C and substrates, 
intermediates, and products were separated on a 12% polyacrylamide/8 M urea gel. The 
gel was transferred to chromatography paper (Whatman 3MM CHR) and dried under 
vacuum. The bands were visualized and quantified on a Molecular Dynamics Storm 860 
Phosphorimager.  
 
Kinetic Studies 
The observed rate constant (kobs) for the individual steps of the TES reaction, 
using each ribozyme construct, was obtained under single-turnover ‘ribozyme excess’ 
conditions.  In these experiments, 35 μL of ribozyme in appropriate buffer was 
preannealed at 60 °C for 5 min and slow cooled to 44 °C. The reactions were initiated by 
the addition of 7 μL of 8 nM 5’-end radiolabeled substrate (10-mer, 5’AUGACUGCUC3’ 
for rPC; 5’CUCUCUGAAAGGU3’ for rT-X; or 5’GACUCUGCUUA3’ for rC), bringing 
the final concentration to 1.3 nM substrate. A 3 μL aliquot was periodically removed and 
added to an equal volume of stop buffer. The reactants and products were separated on a 
12% polyacrylamide/8 M urea gel, and the gel was dried under vacuum. The resulting 
bands were visualized and quantified as described above. The observed rate constants for 
the substrate cleavage step (substrate cleavage plus TES product over time) and for exon 
ligation (TES product over time) were quantified as previously described (8). 
 
RESULTS 
 
 To simplify the comparison of the individual ribozyme constructs, our simplest 
TES model test system was utilized. Successful TES reactions will result in the excision 
of a single nucleotide from within their ribozyme-specific substrates. For these studies, 
the previously constructed Tetrahymena and Candida ribozymes were modified in two 
ways (see Figure 5.2). First, the initial ribozyme constructs lacked the nucleotides 
required to form the P10 helix (RE3), and so an RE3 region (native to the ribozyme) was 
added. As seen for the Pneumocystis ribozyme, P10 helix formation has been shown to 
aid in binding the 3’ exon region of TES substrates (18). Second, the 3’-end of each 
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ribozyme sequence was modified to resemble the Pneumocystis ribozyme (see Chapter 
3), including the addition of a terminal guanosine as it is required as the intramolecular 
nucleophile in the substrate cleavage reaction (Chapter 3). 
 
TES Reactions Conducted with the Pneumocystis, Tetrahymena, and Candida Ribozymes.  
As a control, the TES reaction using the previously characterized Pneumocystis 
(rPC) ribozyme (8) was run (Figure 5.2). TES reactions conducted with 5’-end 
radiolabeled substrate (5’AUGACUGCUC3’, underlined nucleotides are excised in TES 
reactions) resulted in the expected 9-mer product (5’AUGACUCUC3’) and 6-mer 
intermediate (5’AUGACU3’) (Figure 5.3A, Lanes G-H). TES reaction conditions were 
optimized for magnesium concentration, time, and ribozyme concentration for maximum 
TES product yields (Figure 5.3B). Optimized TES reaction conditions resulted in 68.5 ± 
4.4% TES product yield, with an observed rate constant, kobs, of 5.0 ± 1.1 min-1 for 
substrate cleavage and 3.2 ± 0.1 min-1 for exon ligation. Note, optimized TES reactions 
conditions are compiled in Table 5.1. 
For the Tetrahymena (rT-X) ribozyme, TES reactions conducted with 5’-end 
radiolabeled substrate (5’CUCUCUGAAAGGU3’, underlined nucleotides are excised in 
TES reactions) resulted in the predicted 12-mer product (5’CUCUCUAAAGGU3’) and 6-
mer intermediate (5’CUCUCU3’) (Figure 5.4A, Lanes G-H). Optimized TES reactions 
resulted in 47.5 ± 0.2% TES product yield (Figure 5.4B), with an observed rate constant, 
kobs, of 0.17 ± 0.05 min-1 for substrate cleavage and 0.14 ± 0.02 min-1 for the exon 
ligation (Table 5.1).  
For the Candida (rC) ribozyme, TES reactions conducted with 5’-end 
radiolabeled substrate (5’GACUCUGCUUA3’, underlined nucleotides are excised in TES 
reactions) resulted in the predicted 10-mer product (5’GACUCUCUUA3’) and 6-mer 
intermediate (5’GACUCU3’) (Figure 5.5A, Lanes G-H). Optimized TES reactions 
conditions resulted in 50 ± 1.3% TES product yield (Figure 5.5B), with an observed rate 
constant, kobs, of 0.31 ± 0.01 min-1 for substrate cleavage reaction and 0.34 ± 0.03 min-1 
for exon ligation (Table 5.1). These results demonstrate that the Tetrahymena and 
Candida ribozymes can catalyze the excision of a single nucleotide from within their 
ribozyme-specific substrates, through the TES reaction. 
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The Tetrahymena and Candida Ribozymes Catalyze the Substrate Cleavage Reaction 
through Intramolecular Transesterification.  
In the absence of an exogenous guanosine cofactor, the substrate cleavage 
reaction can be catalyzed through two distinct reaction mechanisms. These include 
ribozyme-mediated 5’ hydrolysis (12, 16) and intramolecular transesterification (13, 15, 
17, 68). For the Pneumocystis ribozyme, the 3’ terminal guanosine catalyzes substrate 
cleavage through an intramolecular transesterification reaction (see Chapter 3). Given 
that the Tetrahymena and Candida ribozyme constructs were synthesized with 3’ 
terminal guanosines, it is expected that each of these constructs will catalyze their 
substrate cleavage reaction through intramolecular transesterification. With these 
modifications, the two ribozymes would be predicted to catalyze substrate cleavage 
through intramolecular transesterification.  
As seen for the Pneumocystis ribozyme, the two substrate cleavage reaction 
mechanisms can be distinguished by utilizing 3’-end radiolabeled substrates. This is 
because the size of the TES reaction intermediates will differ depending upon whether 
the substrate cleavage step is hydrolysis or intramolecular transesterification (Chapter 3). 
For the Tetrahymena ribozyme, TES reactions were conducted with 3’-end labeled 
substrate (5’CUCUCUGAAAGGUC3’), which resulted in the predicted 13-mer product 
(5’CUCUCUAAAGGUC3’), as well as the predicted higher molecular weight product 
band (Figure 5.4A, Lanes I-J). The absence of the predicted hydrolysis product 
(5’GAAAGGUC3’), suggests the Tetrahymena ribozyme undergoes intramolecular 
transesterification. 
For the Candida ribozyme, TES reactions were conducted using 3’-end 
radiolabeled substrate (5’GACUCUGCUUAC3’), which resulted in the predicted 11-mer 
product (5’GACUCUCUUAC3’), as well as the predicted high molecular weight product 
band (Figure 5.5A, Lanes I-J). Again the absence of the predicted hydrolysis product (6-
mer, 5’GCUUAC3’), suggests that the Candida ribozyme catalyzes substrate cleavage 
through intramolecular transesterification. 
 As a control, TES reactions were conducted with the Pneumocystis ribozyme 
using 3’-end labeled substrate (5’AUGACUGCUCC3’). TES reactions resulted in the 
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expected 12-mer product (5’AUGACUCUCC3’) and the expected high molecular weight 
product band (Figure 5.3A, lanes I-J). 
 
Competition Between Exogenous Guanosine and Endogenous Guanosine for the GBS 
Inhibits the TES Reaction.  
Apparently, the Tetrahymena and Candida ribozymes catalyze the substrate 
cleavage reaction through an intramolecular transesterification reaction mechanism. The 
Pneumocystis ribozyme catalyzes the substrate cleavage reaction ~20-fold faster, 
however, than either the Tetrahymena or Candida ribozyme (see Table 5.1). This 
observed decrease in rate could be directly related to the ribozymes’ ability to utilize their 
3’ terminal guanosines for substrate cleavage. For a previously described Tetrahymena 
ribozyme (17), competition assays using exogenous guanosine, were used as a probe for 
the ribozymes ability to productively bind their terminal guanosine. In these assays, the 
exogenous guanosine can compete with the ribozymes terminal guanosine for binding to 
the GBS. Using a similar strategy, inhibition of TES product formation could be directly 
correlated to the ribozymes ability to effectively bind its terminal guanosine into the 
GBS. 
 For the Pneumocystis ribozyme, TES reactions were conducted with increasing 
concentrations of rGTP under optimal TES reaction conditions (Table 5.1). The results 
demonstrate that TES product formation is not completely hindered until excessively 
high concentrations of rGTP (10 mM) are added (Figure 5.3C). For the Tetrahymena 
ribozyme, TES reactions resulted in complete inhibition of TES product formation at 
much lower rGTP concentrations (0.02 mM) (Figure 5.4C). In the case of the Candida 
ribozyme, TES reactions demonstrate that low concentrations of rGTP (0.04 mM) are 
also effective at completely hindering TES product formation (Figure 5.5C). These 
results suggest that the Pneumocystis ribozyme binds its terminal guanosine (G336) more 
effectively than either the predicted terminal guanosine of the Tetrahymena ribozyme 
(G416) or the Candida ribozyme (G374). 
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DISCUSSION 
 
 In this report, group I intron-derived ribozymes from Tetrahymena and Candida 
were shown to be capable of catalyzing the excision of internal segments (in this case a 
single nucleotide) from within their native 5’ and 3’ exon sequences. Furthermore, the 
Tetrahymena and Candida ribozyme constructs were shown to catalyze the substrate 
cleavage reaction through an intramolecular transesterification mechanism, using their 
predicted 3’ terminal guanosines as the nucleophiles. This is the first report that group I 
intron-derived ribozymes other than Pneumocystis can catalyze the excision of internal 
segments from RNA transcripts via the TES reaction. 
 
The Tetrahymena Ribozyme 
The Tetrahymena and Pneumocystis ribozymes catalyze the individual steps of 
the TES reaction under similar optimized magnesium, time, and ribozyme conditions (see 
Table 5.1). The results, however, show that the Pneumocystis ribozyme catalyzes the 
individual steps of the TES reaction with higher yields than the Tetrahymena ribozyme. 
Furthermore, the Pneumocystis ribozyme catalyzes substrate cleavage ~30-fold faster 
than the Tetrahymena ribozyme (Table 5.1). In addition, the Pneumocystis ribozyme 
catalyzes exon ligation ~20-fold faster than the Tetrahymena ribozyme. 
One reason that could explain the differences seen for the Tetrahymena and 
Pneumocystis ribozymes is that additional nucleotides, other than guanosine, are being 
added to the 3’-end of these ribozymes during in vitro transcription. The non-encoded 
addition of nucleotides to the 3’-end of RNA transcripts has previously been shown to be 
a consequence of run-off transcription utilizing T7 RNA polymerase (92). The 
Pneumocystis ribozyme, however, has been shown to catalyze its own 3’-end activation, 
which would result in the removal of these additional nucleotides (see Chapter 3). In 
contrast, previously characterized Tetrahymena ribozymes that catalyze intramolecular 
transesterification reactions had to be activated by subjecting the ribozyme to a site-
specific 3’ hydrolysis reaction (13, 15, 17, 97). It is unknown whether this pre-activation, 
which is not necessary for Pneumocystis, would have aided in the Tetrahymena reaction. 
Therefore, the Tetrahymena ribozyme may be hindered in its ability to catalyze site-
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specific 3’ hydrolysis reactions under the prevailing TES reaction conditions, which 
could lead to a lower population of active ribozyme. 
Alternatively, or in addition, the Tetrahymena ribozyme may catalyze reactions 
different from TES. For instance, a higher molecular weight product band is present with 
TES reactions conducted with 5’-end labeled substrates (Figure 5.4A). This high 
molecular weight product band is predicted to be the result of a previously characterized 
ribozyme-mediated reverse-splicing reaction (79, 80). In this reaction, the ribozyme 
becomes embedded between the 5’ and 3’ exon regions of its RNA substrate. Note that 
this higher molecular weight product band is absent for TES reactions conducted with the 
Pneumocystis ribozyme. That the Tetrahymena ribozyme can potentially catalyze this 
reaction is due to the addition of a guanosine to the 5’-end of the ribozyme coding 
sequence (added to facilitate efficient in vitro transcription). If in fact the reverse-splicing 
is occurring, then two competing reactions (TES and reverse-splicing) will 
simultaneously be occurring, which could explain the lower efficiency of the 
Tetrahymena ribozyme reactions. 
In addition, previously characterized Tetrahymena ribozymes (68, 69, 142), which 
closely resemble our Tetrahymena ribozyme construct, are susceptible to both hydrolysis 
and intramolecular cyclization reactions in the absence of substrate (68, 69, 142). Both of 
these reactions result in either a truncated or circular ribozyme product (68, 69, 142). If 
either of these reactions is occurring, the result would be a reduction of fully functional 
Tetrahymena ribozyme. Although, we have no evidence for these alternative reactions, 
they could be occurring in small amounts, which would partially explain the lower 
efficiency for the Tetrahymena ribozyme reactions. 
 
The Candida Ribozyme 
The Candida and Pneumocystis ribozymes catalyze the individual steps of the 
TES reaction under similar optimized time and ribozyme conditions (Table 5.1). For the 
Candida ribozyme, however, higher magnesium concentrations are required for optimal 
TES reactivity. Similar to the Tetrahymena ribozyme, the Candida ribozyme was 
observed to catalyze the individual steps of the TES reaction with lower yields than the 
Pneumocystis ribozyme. Moreover, the Candida ribozyme catalyzes substrate cleavage 
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~15-fold slower than the Pneumocystis ribozyme (Table 5.1). In addition, the Candida 
ribozyme catalyzes exon ligation ~10-fold slower than the Candida ribozyme.  
As for the Tetrahymena ribozyme, it is not known if a substantial percentage of 
the population of Candida ribozymes terminates in guanosine. Similarly, it is not known 
if the Candida ribozyme can catalyze a site-specific 3’ hydrolysis reaction prior to 
becoming activated. If the Candida ribozyme is not being activated under prevailing TES 
reaction conditions, this could explain the lower efficiency of the Candida ribozyme 
reactions. 
 Lastly, the Candida ribozyme produces a high molecular weight product band, 
similar to Tetrahymena ribozyme, for TES reactions conducted with 5’-end labeled 
substrates (Figure 5.5A). At higher magnesium concentrations, the amount of this high 
molecular weight product band increases with increasing magnesium concentrations. As 
stated above, if in fact TES and reverse-splicing are simultaneously occurring then the 
lower efficiency observed for the Candida ribozyme would be predicted. 
 
Productive Docking of the 3’ Terminal Guanosine Effects the Overall TES Reaction.  
Prior to the substrate cleavage reaction, it is predicted that the ribozymes 3’ 
terminal guanosine will be bound into the GBS (17, 68). From the competition studies, it 
appears that the terminal guanosine of the Pneumocystis ribozyme is more productively 
bound to the GBS than the Tetrahymena or Candida ribozymes. These results suggest 
that the decrease in binding affinity of the Tetrahymena and Candida ribozymes is 
possibly due to their inability to bind the terminal guanosine into the GBS. This is 
surprising in that the 3’-end of the ribozyme constructs are all similar. 
As seen for ribozyme-mediated intramolecular transesterification reactions, the 3’ 
terminal guanosine is predicted to be aligned into the GBS through helix P9.0 (17, 68). 
For example, a previously described Tetrahymena ribozyme, L21-G414, was predicted to 
align its 3’ terminal guanosine into the GBS through the aid of P9.0 helix formation (17). 
For L21-G414 ribozyme construct, the sequence at the 3’-end of the ribozyme was 
identical to the native intron sequence, thereby allowing the two nucleotides preceding 
the terminal guanosine to be involved in P9.0 helix formation. For our studies, however, 
the 3’ terminal sequence of the Tetrahymena and Candida ribozymes were modified to 
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resemble the Pneumocystis ribozyme. These modifications were made to allow direct 
comparisons between the individual ribozyme constructs and because P9.0 was shown 
not to be required (19). As a result, the sequences preceding the terminal guanosine are 
not predicted to form the P9.0 helix. Therefore, to enhance the ωG binding affinity of the 
Tetrahymena and Candida ribozymes, one strategy to try might be to modify the 3’ 
sequence back to the native intron sequence. Nevertheless, our results demonstrate that 
all three constructs, in their current incarnations, effectively catalyze the TES reaction. 
 
Comparison with Previous Results 
 A previously characterized Tetrahymena ribozyme that lacks both the 5’ and 3’ 
exon sequences and the RE1 and RE3 sequences is capable of catalyzing a TES-like 
reaction (143). This highly truncated Tetrahymena ribozyme was shown to be capable of 
binding pseudoknot structures in trans resulting in the formation of P1 and P10 helices. 
For TES ribozymes, the individual ribozyme constructs contain the nucleotides required 
for the P1 and P10 helices. Unlike the TES reaction, this reaction requires high 
magnesium concentrations (10-100 mM), high temperatures (55-65 °C), and an 
exogenous guanosine cofactor. For our studies, TES reactions conducted with the 
individual ribozymes were optimized at lower magnesium concentrations (10-25 mM) at 
lower temperatures (44 °C), and do not require an exogenous guanosine cofactor. 
 Most recently, an engineered twin ribozyme has been shown to mediate the 
excision of an internal segment from within an RNA substrate (144). In this reaction, 
excision is mediated by an exchange reaction, consisting of two cleavage and two ligation 
reactions. In addition, two RNA substrates are required for the twin ribozyme approach, 
whereas for TES only one substrate is required. The reaction conditions for the twin 
ribozyme reaction are similar to TES conditions, however, prohibitively long incubation 
times (8 h) are required as compared to 30-45 min for TES. Furthermore, the product 
yield for the twin ribozyme-mediated excision reaction is considerably lower (17%) than 
we get with TES reactions conducted with Pneumocystis ribozyme (68%). 
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Table 5.1. Optimized TES reaction conditions for the Pneumocystis, Tetrahymena, and Candida 
ribozyme constructs 
Optimized TES reactions conditionsa TES product yield and observed rate 
constants for substrate cleavage and exon 
ligation reactionsb
  
MgCl2 
(mM) 
 
Time 
(min) 
 
Ribozyme 
(nM) 
 
TES product 
(%) 
 
Substrate 
Cleavage 
 (kobs min-1) 
 
Exon 
Ligation 
(kobs min-1) 
       
Pneumocystis  15 30 100 68.5 ± 4.4 5.0 ± 1.1 3.2 ± 0.1 
Tetrahymena  10 45 166 47.5 ± 0.18 0.17 ± 0.05 0.14 ± 0.02 
Candida 25 30 75 50.0 ± 1.5 0.31 ± 0.01 0.34 ± 0.03 
aThe individual ribozyme constructs were optimized for magnesium concentration, time, and 
ribozyme concentration for maximum TES product yields. bThe observed rate constants, kobs, 
were obtained for the substrate cleavage and exon ligation reactions under single turnover 
conditions. 
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Trans Excision-Splicing Reaction 
Binding 
Substrate Cleavage Nucleophilic attack by 
terminal guanosine (G336) 
Exon Ligation Nucleophilic attack by 
uridine 
TES Substrate
TES Product
(RE3)(RE1)
(RE2)
3’
5’
Ribozyme
5’ 5’ Exon 3’3’ Exon
Bridge
5’
P10 (RE3)P1 (RE1)
P9.0 (RE2)
5’
3’
(RE3)P1 (RE1)
P9.0 (RE2)
3’
5’
5’ 3’
P9.0 (RE2)
3’
5’
Ribozyme
5’ 5’ Exon 3’3’ Exon
Bridge
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Diagram of the ribozyme-mediated trans excision-splicing reaction. The 
Pneumocystis carinii ribozyme is denoted in gray lines and the 5’ and 3’ exon sequences 
are denoted by black lines. The black square within the 5’ exon region denotes a uridine 
and the gray circle adjacent to the 3’ exon region denotes a guanosine (ωG). The bridge 
region, to be excised, is denoted as a dotted line. The P1 helix is formed through base-
pairing of recognition element 1 (RE1) with the 5’ exon. The P10 helix is formed through 
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base-pairing of recognition element 3 (RE3) with the 3’ exon. The first step (substrate 
cleavage) is catalyzed by G336 (open circle at 3’-end of ribozyme) resulting in the 
covalent attachment of the 3’-end of the substrate to the 3’-end of the ribozyme. The 
second step (exon ligation) proceeds through attack of the uridine upon the ωG of the 
substrate, resulting in ligation of the flanking sequences. Note that the product of the TES 
reaction is that ωG (of substrate) remains attached to the 3’-end of the ribozyme. 
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Figure 5.2. Diagram of Pneumocystis carinii (rPC), Tetrahymena thermophila (rT-X), 
and C. albicans (rC) ribozyme constructs. The sequence P. carinii, T. thermophila, and 
C. albicans ribozyme constructs are shown in uppercase letters with their respective 
substrate shown in lowercase letters. Note, only the sequences that are involved with 
binding the individual substrates are shown. The remaining ribozyme sequences, 
represented with a line, are different for each of the constructs. The nucleotide to be 
excised (ωG) is circled for all three ribozyme constructs. 
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Figure 5.3. TES reactions conducted with the Pneumocystis carinii (rPC) ribozyme. A. 
Polyacrylamide gel representing substrates and products from TES reactions using both 
5’ and 3’-end radiolabeled substrates using 100 nM rPC, 15 mM MgCl2, at 30 min at 44 
°C. Lanes A, C, and E contain 5’-end radiolabeled 10-mer, 9-mer, and 6-mer size 
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controls. Lanes B, D, and F contain 3’-end radiolabeled 10-mer, 9-mer, and 4-mer size 
controls. Note that the 3’-end radiolabeled size controls are one nucleotide larger than 5’-
end radiolabeled size controls. Gel lanes containing a plus (+) sign show reactions 
conducted in H15Mg and lanes containing a minus (-) sign show reactions conducted in 
H0Mg. Lanes G-J contain the normal rPC ribozyme with 5’-end radiolabeled 13-mer 
(lanes G and H) or 3’-end radiolabeled 13-mer (lanes I and J). B. Graphs of optimization 
of TES reactions using 5’-end radiolabeled 13-mer substrate for magnesium 
concentration, time, and ribozyme concentration. All reactions were conducted as above 
except for the changing variable. C. Graph of rGTP concentration dependence for TES 
reactions conducted with the rPC ribozyme. All data points represent the average of at 
least two independent reactions, with standard deviations typically below 10%. Note for 
all graphs, the 9-mer TES product is represented by filled circles and the substrate 
cleavage product, 6-mer, is represented as open circles. 
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Figure 5.4. TES reactions conducted with the Tetrahymena thermophila (rT-X) ribozyme. 
A. Polyacrylamide gel representing substrates and products from TES reactions using 
both 5’ and 3’-end radiolabeled substrates using 166 nM rT-X, 10 mM MgCl2, at 45 min 
at 44 °C. Lanes A, C, and F contain 5’-end radiolabeled 13-mer, 12-mer, and 6-mer size 
Pr
od
uc
t F
or
m
at
io
n
MgCl2 (mM)
0
20
40
60
80
100
0 5 10 15 20 25
Pr
od
uc
t F
or
m
at
io
n
BA 
 
A B C D
++ --
E F G H I J
Substrate 
Product 
Intermediate (3’) 
Intermediate (5’) 
5’ 3’3’5’3’ 3’ 5’5 5’ 3’
Pr
od
uc
t F
or
m
at
io
n
Time (min)
0
20
40
60
80
100
0 15 30 45
Pr
od
uc
t F
or
m
at
io
n
Pr
od
uc
t F
or
m
at
io
n
Ribozyme (nM)
0
20
40
60
80
100
0 100 200 300 400 500
Pr
od
uc
t F
or
m
at
io
n
rGTP (mM)
Pr
od
uc
t F
or
m
at
io
n
0
20
40
60
80
100
0 0.01 0.02 0.03
Pr
od
uc
t F
or
m
at
io
n
C
99 
controls. Lanes B, D, and E contain 3’-end radiolabeled 13-mer, 12-mer, and 7-mer size 
controls. Note that the 3’-end radiolabeled size controls are one nucleotide larger than 5’-
end radiolabeled size controls. Gel lanes containing a plus (+) sign show reactions 
conducted in H10Mg and lanes containing a minus (-) sign show reactions conducted in 
H0Mg. Lanes G-J contain the normal rT-X ribozyme with 5’-end radiolabeled 10-mer 
(lanes G and H) or 3’-end radiolabeled 10-mer (lanes I and J). B. Graphs of optimization 
of TES reactions using 5’-end radiolabeled 13-mer substrate for magnesium 
concentration, time, and ribozyme concentration. All reactions were conducted as above 
except for the changing variable. C. Graph of rGTP concentration dependence for TES 
reactions conducted with the rT-X ribozyme. The data represents the average of at least 
two independent reactions, with standard deviations typically below 10%. All data points 
represent the average of at least two independent reactions with standard deviations 
typically below 10%. Note for all graphs, the 12-mer TES product is represented by filled 
triangles and the substrate cleavage product, 6-mer, is represented as open triangles. 
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Figure 5.5. TES reactions conducted with the Candida albicans (rC) ribozyme. A. 
Polyacrylamide gel representing substrates and products from TES reactions using both 
5’ and 3’-end radiolabeled substrates using 75 nM rC, 25 mM MgCl2, at 30 min at 44 °C. 
Lanes A, C, and E contain 5’-end radiolabeled 11-mer, 10-mer, and 6-mer size controls. 
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Lanes B, D, and F contain 3’-end radiolabeled 11-mer, 10-mer, and 5-mer size controls. 
Note that the 3’-end radiolabeled size controls are one nucleotide larger than 5’-end 
radiolabeled size controls. Gel lanes containing a plus (+) sign show reactions conducted 
in H25Mg and lanes containing a minus (-) sign show reactions conducted in H0Mg. 
Lanes G-J contain the normal rC ribozyme with 5’-end radiolabeled 10-mer (lanes G and 
H) or 3’-end radiolabeled 10-mer (lanes I and J). B. Graphs of optimization of TES 
reactions using 5’-end radiolabeled 11-mer substrate for magnesium concentration, time, 
and ribozyme concentration. All reactions were conducted as above except for the 
changing variable. C. Graph of rGTP concentration dependence for TES reactions 
conducted with the rC ribozyme. All data points represent the average of at least two 
independent reactions, with standard deviations typically below 10%. Note for all graphs, 
the 11-mer TES product is represented by filled triangles and the substrate cleavage 
product, 6-mer, is represented as open triangles. 
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CHAPTER SIX-INSERTION OF MODIFIED OLIGORIBONUCLEOTIDES 
UITLIZING THE TRANS INSERTION-SPLICING REACTION 
 
INTRODUCTION 
 
 The site-specific modification of RNA, specifically the incorporation of modified 
nucleotides, has greatly increased our fundamental understanding of RNA structure and 
function (145-147). To date, several strategies have been developed for the site-specific 
alteration of RNA, including the addition of a modified nucleotide(s) (148-157). These 
include the chemical synthesis of RNA using existing phosphoramidite strategies. In 
addition, chemical and enzymatic ligation strategies have been developed, which take 
advantage of the unique properties of the termini of RNA (148-150). Strategies 
substituting modified nucleosides or using unnatural base-pair combinations during in 
vitro transcription reactions have also been developed (151-155). Furthermore, a twin 
ribozyme was engineered to replace an internal segment of RNA with a modified 
nucleotide (156). Most recently, a deoxyribozyme was engineered for the insertion of 
modified nucleotides (157). In some cases, however, existing strategies suffer from a lack 
of product specificity, low product yields, long reaction times, and are limited by the 
types of modified nucleotides that can be incorporated. 
The trans insertion-splicing (TIS) reaction, catalyzed by a group I intron-derived 
ribozyme from Pneumocystis carinii (P. carinii), was recently developed to sequence-
specifically insert a predefined RNA sequence into a target RNA substrate (10). The TIS 
reaction, which utilizes two separate RNA substrates, has been proposed to proceed 
through three separate chemical steps. These include two consecutive substrate cleavage 
steps and a single exon ligation step (Figure 6.1). 
To increase the general applicability of the TIS reaction, TIS was investigated as a 
new strategy for the insertion of modified oligonucleotides. Four modified 
oligonucleotides were designed to test modifications at either the 2’ position of the sugar 
ring (deoxy), the phosphodiester backbone (phosphothioate), or the base (2-aminopurine 
or 4-thiouridine) position. All four modified oligonucleotides were shown to be inserted 
sequence-specifically within their intended target. In addition, a doubly modified 
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oligonucleotide, including a methoxy and deoxy substitution, was shown to be an 
effective substrate for the insertion of multiple modified oligonucleotides. The results 
demonstrate TIS as an alternative strategy for the insertion of modified nucleotides into 
RNA, including multiple modified nucleotides. The TIS strategy could potentially lead to 
a more effective method for the creation of full-length RNA transcripts containing these 
site-specific modifications.  
 
MATERIALS AND METHODS 
 
Oligonucleotide Synthesis and Preparation 
DNA oligonucleotides were obtained from Integrated DNA Technologies 
(Coralville, IA) and were used without further purification. RNA oligonucleotides were 
obtained from Dharmacon Research, Inc. (Lafayette, CO) and were deprotected using the 
manufacturer’s standard protocol. Concentrations of individual oligonucleotides were 
calculated from UV absorption measurements using a Beckman DU 650 
spectrophotometer (Beckman Coulter, Inc.; Fullerton, CA). RNA oligonucleotides were 
5’-end radiolabeled by phosphorylation of the 5’ terminal hydroxyl group with [γ-32P] 
ATP (Amersham Pharmacia Biotech; Piscataway, NJ) using T4 polynucleotide kinase 
(New England Biolabs; Beverly, MA) as previously described (75). The sequences of the 
substrates used are shown in Table 6.1. 
  
Ribozyme Synthesis 
The previously constructed PC plasmid (8) was linearized in a 50 μL reaction 
consisting of 16 μg of plasmid, 1 X REACT 2 buffer, and 50 units XbaI (Invitrogen) at 
37 °C for 2 h. The resulting linearized plasmid was isolated using the QIAquick PCR 
purification kit (Qiagen) using the manufacturers protocol. Run-off transcription was 
performed for 2 h in a 50 μL reaction consisting of 1 μg linearized DNA template, 50 
units of T7 RNA polymerase (New England Biolabs; Beverly, MA), 40 mM Tris-HCl 
(pH 7.5), 10 mM MgCl2, 5 mM DTT, 5 mM spermidine, and 1 mM rNTPs. The rPC 
ribozyme was purified using a Qiagen Plasmid Midi Kit (Qiagen), as previously 
described (8). Ribozyme concentrations were calculated from UV absorption 
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measurements using a Beckman DU 650 spectrophotometer (Beckman Coulter, Inc). 
 
TIS Reactions 
TIS reactions were conducted under previously optimized reaction conditions 
using the rPC ribozyme (9). Briefly, a 5.0 μL ribozyme solution consisting of 240 nM 
rPC in H10Mg (50 mM HEPES (25 mM Na+). 135 mM KCl, and 10 mM MgCl2 at pH 
7.5) was pre-incubated at 60 °C for 5 min followed by slow cooling to 44 °C. A separate 
solution consisting of 6 nM 5’-end radiolabeled TIS substrate (5’AUGACUAAACAU3’) 
and 30 μM of the individual TIS inserts (5’GCUCUCGUG3’, underlined nucleotides 
denote the sites of modification) in H10Mg was pre-incubated at 44 °C. TIS reactions 
were initiated by the addition of 1.0 μL of the precombined TIS donor and acceptor 
substrates to the ribozyme solution. This results in a final concentration of 200 nM rPC 
ribozyme, 1.0 nM TIS acceptor substrate, and 1.0 μM TIS donor substrate. TIS reactions 
were conducted for 2 h at 44 °C, at which time the reaction was terminated by addition of 
an equal volume (6 μL) of a 2X stop buffer (10 M urea, 3 mM EDTA, and 0.1X TBE). 
The reaction mixture was denatured for 1 min at 90 °C and separated on a 12% 
polyacrylamide/8 M urea gel. The gel was transferred to chromatography paper and dried 
under vacuum. The bands were visualized and quantified on a Molecular Dynamics 
Storm 860 Phosphorimager.  
 
RESULTS 
 
Design of the TIS Test System 
It has previously been shown that a group I intron-derived ribozyme from P. 
carinii (rPC) can catalyze the TIS reaction, as shown in Figure 6.1 (9). For these previous 
studies, the sequence of the ribozyme was kept intact, albeit truncated, and the donor and 
acceptor substrates closely mimicked the ribozymes native 5’ and 3’ exon sequences. 
Maintaining these sequences was important in order to maximize the binding and 
subsequent reactivity of the tri-component system during the original proof-of-concept 
study (10). Therefore, the same ribozyme and substrate sequences were used in this 
study, except for the nucleotide analog substitutions at positions 6-8 (Figure 6.1) within 
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the TIS donor substrate (see Table 6.1). Though positions 6-8 are involved in binding and 
subsequent alignment of TIS substrates, through molecular interactions with the 
ribozyme, these sites were chosen as they would be expected to have the least deleterious 
effect upon the TIS reaction (Figure 6.2). To determine the generality of the method, 
nucleotides that contain sugar, phosphate, and nucleobase modifications were analyzed. 
These include deoxyribose (dG), methoxyribose (mU), phosphorothioate (SH), 2-
aminopurine (2AP), and 4-thiouridine (4SU) substitutions (Table 6.1). Note that for each 
of the donor substrates, the same sized TIS product is expected to form, which is the 
same size as that with the previously sequenced unmodified substrate (10). 
 
TIS Insertion of Modified Oligoribonucleotides 
 TIS reactions were conducted as previously described (10), under previously 
optimized reaction conditions (see Figure 6.3 legend). Substrates, intermediates, and 
products of each of the individual TIS reactions were separated and visualized via 
polyacrylamide gel electrophoresis. The initial reactions focused on modifications only at 
position 7, as this was expected to be least disruptive to the reaction. As shown in Figure 
6.3, each of the four substrates modified at position 7 resulted in the expected 18-mer 
product band (Lanes F-J). Note that the relatively small size differences between the TIS 
products are due to different modifications within the substrates. Apparently, position 7 
of the donor substrate is readily modifiable; resulting in the effective insertion of 
modified RNAs into other RNAs (see reaction yields in Table 6.2). At position 7, the 
deoxy (Figure 6.3, lane G) and phosphothioate (Figure 6.3, lane H) substitutions were 
essentially as effective as the non-modified substrate (Figure 6.3, lane F). TIS product 
yields for the deoxy was 72 ± 0.8% and 65 ± 0.2% for the phosphothioate, compared to 
68 ± 1.8% for the non-modified substrate (Table 6.2). Lower, although comparable, 
yields (59 ± 0.9% versus 63 ± 0.3%) were obtained for the two nucleobase modifications 
(Figure 6.3, lanes I and J). This result suggests that base modifications do hinder TIS 
product formation, most probably through interrupting structural elements within the rPC 
ribozyme utilized during the course of the reaction. Note that the faint second product 
band for TIS reactions conducted with the 4-thiouridine TIS donor substrate (Figure 6.3, 
lane J) is potentially due to degradation of the starting material. 
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It was then tested whether more than one modification could be added to the 
donor substrate. Positions 6 and 8 were analyzed to see if they too could be modified (in 
addition to position 7), and different modifications, including a methoxy substitution and 
a deoxy substitution, were chosen to broaden the potential applicability of the method. As 
shown in Figure 6.3 (Lane K), the doubly modified donor substrate is as effective a TIS 
substrate (75 ± 0.9% product) as its non-modified counterpart. Apparently, the 2’ position 
of the ribose at positions 6 and 8 (in addition to position 7) of the donor substrate are sites 
that can be readily modified. This result shows that the TIS reaction is an effective 
strategy for the insertion of multiple modifications within an RNA transcript. Taken 
together, these results demonstrate that the TIS reaction can be exploited for inserting 
non-native, chemically modified oligonucleotides into RNAs in trans.  
 
DISCUSSION 
  
In this study, it has been demonstrated that the trans insertion-splicing ribozyme 
from P. carinii can utilize substrates that contain modifications, and that this activity can 
be exploited to generate RNAs with one or more internal modifications. In this study, the 
functional group modifications within the sugar phosphate backbone at position 7 of the 
donor substrate (see Figure 6.2) have been shown to not hinder the TIS reaction. In 
contrast, nucleobase modifications at position 7 do reduce TIS yields, although not by 
prohibitive amounts (approximately 15% reduction). These results suggest that disruption 
of the P9.0 helix interaction between this nucleobase and the ribozyme during the second 
TIS reaction step is not prohibitive (see Figure 6.1). Therefore, the TIS reaction is a 
relatively effective method for synthesizing RNAs that contain sugar-phosphate 
backbone and nucleobase modifications. 
 Like that at position 7, ribose modifications at donor substrate positions 6 and 8 
also do not reduce TIS yields. Apparently, the 2’ OH groups at positions 6, 7, and 8 are 
expendable for the TIS reaction, which enhances the flexibility of using TIS as a 
synthetic tool. In addition, that the TIS reaction conducted with the doubly-modified 
donor substrate was successful demonstrates that TIS is an effective strategy for the 
insertion of multiple modified nucleotides within a given RNA sequence.       
107 
 While the products of the TIS reactions in this proof-of-concept study are short 
enough to have been synthesized chemically in high yields, chemically synthesizing large 
RNAs, with or without modifications, is prohibitive due to insufficient expected yields. It 
is envisioned that the TIS reaction could be exploited for the synthesis of large, site-
specifically modified RNAs. This could be accomplished using TIS to insert a small, 
chemically synthesized RNA (acting as the donor molecule, modified at a position 
corresponding to positions 6, 7, or 8 in Figure 6.1) into a full-length RNA transcript 
(acting as the acceptor substrate). Note that in terms of ribozyme design, all of the 
ribozyme and substrate sequences that make up the molecular recognition elements can 
be altered as desired to create appropriate target-substrate combinations, as long as the 
substrate-ribozyme base pairs shown in Figure 6.1 are maintained. In addition, it is 
expected that full-length transcripts could be effective TIS acceptor substrates because a 
similar ribozyme, acting as a trans excision-splicing (TES) catalyst, has already been 
shown to be active on a full-length GFP transcript in vivo (10).  
 
Comparison with Previously Developed Methods 
Enzymatic methods have previously been developed for the incorporation of 
modified nucleotides into large RNAs. One strategy is to add the desired modified 
nucleotide precursor directly into transcription reactions conducted in vitro (151, 152). 
Although this strategy can be quite effective and useful, it is not appropriate for 
synthesizing single site-specific RNAs, as the modified nucleotides are incorporated 
throughout the entire transcript. Another strategy solves this problem by utilizing unique 
non-native nucleotides in the transcription template that only pair with other unique RNA 
nucleotides, thus forming RNAs during transcription that have non-native nucleotides 
incorporated (153-155).  Unfortunately, the numbers of non-native nucleotides that can 
be used in this strategy is extremely limiting. In comparison, the TIS strategy could 
potentially be simpler to design and enact, and is not entirely dependent on the secondary 
structure formation properties of the modified nucleotide(s) for the success of the 
method.   
The enzymatic ligation of separately synthesized RNAs, including RNAs that 
contain modifications, using either RNA or DNA ligases (149, 150, 158-161) have been 
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the most widely used methods for constructing large modified RNAs. Though these 
methods have been quite successful, in some instances, they still suffer from low product 
yields and long reaction times. In addition, the substrates that are used in enzymatic 
ligation methods are typically transcript length, which requires highly precise synthetic, 
purification, and ligation methods. In contrast, the TIS method requires the ribozyme 
(whose sequence has been designed for the particular application), one transcript, and a 
synthetic modified RNA.  
Recently, the site-specific modification of RNA has been accomplished using an 
engineered dual hairpin ribozyme, termed a twin ribozyme (156). In this strategy, the 
ribozyme can replace an internal segment of an RNA transcript with a separate RNA 
which may or may not contain a modification. This method shares many similarities to 
the TIS reaction, including using a catalytic RNA and two exogenous RNA substrates. 
Nevertheless, the two methods differ by the type of the ribozyme (hairpin versus group I 
introns), the required sequence elements in the substrates, the catalytic mechanisms, and 
the optimal reaction conditions. The TIS strategy, however, results in higher product 
yields than the twin ribozyme approach (70% versus 20% product yield), which suggests 
that the TIS strategy could be more efficient at inserting modified oligonucleotides into 
RNA transcripts (156). 
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 Table 6.1. TIS starting material and insert substrate sequences. 
   TIS Acceptor Substrate Sequence 
   
5’AUGACUAAAGAU3’12-mer-starting material 
   Unmodified TIS Donor Substrate Sequence 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9-mer-unmodified insert 5’GCUCUCGUG3’
  
Modified TIS Donor Substrate Sequence 
  
9-mer-deoxyguanosine (dG) 5’GGUCUC(dG)UG3’
9-mer-phosphothioate (SH) 5’GGUCUC(SH)GUG3’
9-mer-2-aminopurine (2AP) 5’GGUCUC(2AP)UG3’
9-mer-4-thiouridine (4SU) 5’GGUCUC(4SU)UG3’
9-mer-doubly modified (DM) 5’GGUCU(dC)G(mU)G3’
  
The sequences for the TIS acceptor substrate (12-mer), normal 
(unmodified) TIS donor substrate (9-mer), and modified TIS 
donor substrates (9-mer) are shown. For both the unmodified 
and modified TIS donor substrates the sequences to be inserted 
are highlighted in gray. For each modified TIS donor substrate 
the modified nucleotide (located at either position C6, G7, or 
U8) is shown in parentheses. The modified TIS donor 
substrates include a deoxyguanosine or deoxycytosine (dG or 
dC), phosphothioate (SH), 2-aminopurine (2AP), 4-thiouridine 
(4SU), or methoxyuridine (mU) substitution. 
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Table 6.2. Percent TIS product formation for individual modified oligonucleotides. 
   
TIS Donor Substrate Predicted TIS Product Sequencea
(18-mer) 
TIS Productb
 
   
9-mer-normal insert 5’AUGACUCUCGUGAAACAU3’ 68±1.8% 
9-mer-deoxyguanosine (dG) 5’AUGACUCUC(dG)UGAAACAU3’ 72±0.8% 
9-mer-phosphothioate (SH) 5’AUGACUCUC(SH)GUGAAACAU3’ 65±0.2% 
9-mer-2-aminopurine (2AP) 5’AUGACUCUC(2AP)UGAAACAU3’ 59±0.9% 
9-mer-4-thiouridine (4SU) 5’AUGACUCUC(4SU)UGAAACAU3’ 63±0.3% 
9-mer-doubly modified (DM) 5’AUGACUCU(dC)G(mU)GAAACAU3’ 75±0.9% 
   
aPredicted TIS product (18-mer) for TIS reactions conducted with the TIS acceptor substrate 
(12-mer) and either the unmodified or modified TIS donor substrates. The sequences 
highlighted in gray represent the insert region including the modified nucleotide(s). TIS 
reactions were conducted under previously optimized reaction conditions (200 nM ribozyme, 
10 mM MgCl2, 1 μM insert at 44 °C for 2 hr). bPercent TIS product (18-mer) formed using 
each of the modified oligonucleotide substrates. The TIS product, 
5’AUGACUCUCGUGAAACAU3’, includes modification at either the C6, G7, or U8 
positions (shown in parentheses) from the TIS donor substrate. 
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Figure 6.1. Schematic representation of the TIS reaction model system. The 
Pneumocystis carinii (rPC) ribozyme is shown in black uppercase lettering including the 
ribozyme recognition elements; RE1, RE2, and RE3 that form the P1, P9.0, and P10 
helices respectively. The 9-mer TIS donor substrate (5’G1C2U3C4U5C6G7U8G93’) is shown 
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terminal guanosine (G336) of the ribozyme performs a nucleophilic attack upon the 5’ 
splice site, resulting in the covalent attachment of the insert region to the 3’-end of the 
ribozyme. The 5’ exon region of the TIS donor substrate dissociates from the ribozyme, 
and the TIS acceptor substrate is bound through a second P1 helix. The ωGi (aligned by 
P9.0 helix formation) performs a nucleophilic attack upon the 5’ splice site in the TIS 
acceptor substrate, resulting in the covalent attachment of the 3’ exon region of the TIS 
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5’AUGACUC4U5C6G7U8G9AAACAU3’).  
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Figure 6.2. Diagram of the modified nucleotides and naming conventions used in this 
study. The normal nucleotide at position 6, 7, and 8 within the TIS donor substrate (9-
mer, 5’G1C2U3C4U5C6G7U8G93’) are shown in addition to the individual modifications to 
the 2’ position of the sugar ring [deoxycytosine (dC), deoxyguanosine (dG), and 
methoxyuridine (mU)], the phosphodiester backbone [phosphothioate (SH)], and base 
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position [2-aminopurine (2AP) and 4-thiouridine (4SU)]. Note each individual 
modification is depicted with a circle.  
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Figure 6.3. Polyacrylamide gel showing substrates, intermediates, and products of the 
trans insertion-splicing reaction. Reactions were conducted with 200 nM ribozyme, 1 nM 
acceptor substrate, and 1 μM donor substrate in H10Mg at 44 °C for 2 h. Lanes A, B, and 
C contain 5’-end radiolabeled 18-mer, 12-mer, and 6-mer size controls respectively. 
Negative control lanes (-) consist of reactions run in H0Mg buffer (Lane D) or without 
rPC ribozyme (Lane E). Lane F contains the TIS reaction with the unmodified donor 
substrate (N), and serves as a positive control. Lanes G, H, I, J, and K contain the TIS 
reaction with deoxy (dG), phosphothioate (SH), 2-aminopurine (2AP), 4-thiouridine 
(4SU), and doubly-modified (DM) substituted donor substrates, respectively.  
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CHAPTER SEVEN-FUTURE DIRECTIONS 
 
The Trans Excision-Splicing Reaction 
 The trans excision-splicing (TES) reaction has been envisioned as a potential 
therapeutic strategy for the correction of defective RNA transcripts within a cell. In this 
strategy, the Pneumocystis carinii ribozyme would be engineered to excise specific 
regions from within defective RNA transcripts. The resulting corrected version of the 
transcript will lead to the production of a functional protein. As seen for other ribozyme-
mediated reactions, similar to the TES reaction, repairing as little as 10% of these 
transcripts has beneficial effects for an underlying genetic mutation (85, 88). The work 
presented herein has answered some of the questions relating to the TES reaction with 
respect to the overall reaction mechanism.  
 
Intramolecular Transesterification Reaction for Cleavage of TES Substrates 
 The work presented herein has established a mechanistic framework for the 
substrate cleavage step of the TES reaction. Substrate cleavage was shown to be a 
ribozyme-mediated intramolecular transesterification reaction, catalyzed by the 3’ 
terminal guanosine (G336) of the Pneumocystis carinii ribozyme. The direct consequence 
of the intramolecular transesterification reaction is that the bridge-3’ exon region of TES 
substrates will be covalently attached to the 3’-end of the Pneumocystis ribozyme. Proof 
of the mechanism was obtained through sequencing of ribozyme reaction intermediates 
isolated from in vitro and in vivo TES reactions. The results obtained confirmed the 
presence of the expected ribozyme intermediate.  
Though the mechanism for the substrate cleavage step of TES was established, 
several questions arise with respect to enhancing the reactions specificity and efficiency 
in vitro and in vivo. For instance, it is not known how effectively the Pneumocystis 
ribozyme terminates in the required 3’ terminal guanosine. As future TES reactions will 
undoubtedly be conducted in eukaryotic cell lines, enhancing the ribozymes ability to 
terminate in a guanosine is critical. For instance, a Pneumocystis ribozyme, expressed 
within a eukaryotic cell line (HeLa), lacking a 3’ terminal guanosine resulted in a 
ribozyme incapable of catalyzing the TES reaction. To address this concern, the 
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percentage of Pneumocystis ribozymes that terminate in guanosine could be obtained 
through 3’ rapid amplification of cDNA ends (RACE). This strategy could be used both 
in vitro and in vivo to distinguish between active and inactive forms of the Pneumocystis 
ribozyme. 
To date, it is unknown how effectively the 3’ terminal guanosine (G336) of the 
Pneumocystis ribozyme is aligned into the guanosine binding site (GBS). If the terminal 
guanosine is found to be poorly aligned into the GBS, the molecular recognition elements 
of the ribozyme could be modified to enhance this alignment. Specifically, the two 
nucleotides, which constitute recognition element 2 (RE2), could be altered to base-pair 
with the two nucleotides preceding G336 of the ribozyme. This would lead to a P9.0 
helix interaction, which has been shown to aid in the alignment of the 3’ terminal 
guanosine for other ribozyme-mediated reactions (17).  
If intramolecular 3’ hydrolysis is shown to be inefficient at creating the active 
form of the Pneumocystis ribozyme in vivo, the ribozyme could potentially be 
reengineered. This would involve including both a P9.0 and P10 helix interaction, which 
could potentially increase the efficiency of the hydrolysis reaction. As Pneumocystis 
ribozymes expressed in vivo will likely have transcription termination sequences defining 
their 3’-ends, enhancing the intramolecular 3’ hydrolysis reaction will increase the 
likelihood of successful TES reactions. 
Lastly, it has been shown that the substrate cleavage reaction in vivo is not highly 
sequence-specific. For example, the Pneumocystis ribozyme was previously shown in 
vivo to be capable of cleaving a second site within its target RNA transcript. To address 
this concern, the Pneumocystis ribozyme could be reengineered to include an extended 
guide sequence (83, 84, 86-90) to aid in enhancing the binding of the ribozyme to the 
intended RNA transcript. Though there are many questions still to be answered for the 
TES reaction, the mechanistic investigation presented in this work has laid a foundation 
for future studies for improving the overall TES reaction in vitro and in vivo. 
 
Kinetic Characterization of the Substrate Cleavage Reaction of the TES Reaction 
 The work presented herein has established a kinetic framework for the substrate 
cleavage step of the TES reaction. Several conclusions can be drawn from the kinetic 
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framework, including that the rate constant for the substrate cleavage reaction is 
approximately 60-fold lower than a previously reported Tetrahymena thermophila 
ribozyme. The rate constant for substrate cleavage is only 4-fold greater than that for 
substrate dissociation. Furthermore, the rate of product dissociation is slower than the rate 
of substrate cleavage, which curtails the possibility of multiple-turnover reactions. Lastly, 
the results indicate that a conformational change exists between the two steps of the TES 
reaction. 
The kinetic study has been informative for increasing our understanding of the 
fine details by which the substrate cleavage step proceeds. The conclusions that can be 
drawn from the kinetic data, however, suggest strategies whereby we could enhance the 
rate and yield of the substrate cleavage reaction. For example, the relatively slow rate of 
product dissociation is potentially rate-limiting for any potential multiple-turnover 
reactions. To increase the rate of product dissociation, the ribozyme could be 
reengineered to weaken the binding of TES products, for example by shortening helix P1. 
A shortened P1 helix has previously been shown to increase the rate of product 
dissociation for a group I intron-derived ribozyme from Anabaena (72).   
Separately, the rate of substrate dissociation was shown to be comparable to the 
rate of substrate cleavage. This suggests that a substantial amount of substrate will 
dissociate prior to the substrate cleavage reaction. To slow the rate of substrate 
dissociation, the ribozyme could be reengineered to strengthen the binding of TES 
substrates, for example by elongating helix P1. Elongating helix P1, however, could 
strengthen the binding of TES products, which could decrease the rate of product 
dissociation even further. Therefore, TES ribozymes would have to be designed to 
include a P1 helix, of optimal length, to overcome the limitations set by the rates for 
substrate and product dissociation. Lastly, the length of helix P1 would have to 
investigated to determine the effects upon the specificity of the TES reaction. 
 
Group I Intron-Derived Ribozyme Catalyze the Trans Excision-Splicing Reaction 
 The work presented herein has demonstrated that the TES reaction is generally 
applicable to other group I intron-derived ribozymes. A group I intron-derived ribozyme 
from Tetrahymena thermophila and Candida albicans were shown to catalyze the 
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excision of a single nucleotide from within their respective RNA substrate. Moreover, 
both ribozyme constructs catalyze the substrate cleavage step through an intramolecular 
transesterification reaction, similar to the Pneumocystis carinii ribozyme. The 
Tetrahymena and Candida ribozymes, however, were shown to catalyze the individual 
steps of the TES reaction less efficiently than the Pneumocystis ribozyme. The decrease 
in efficiency was attributed to the Tetrahymena and Candida ribozymes inability to 
effectively bind their terminal guanosine into the GBS. To increase the ribozymes affinity 
for their terminal guanosine, the ribozymes’ RE2 recognition elements, could be 
modified (to form helix P9.0) to aid in aligning their terminal guanosines. 
 That additional group I intron-derived ribozymes can catalyze the TES reaction, 
raises questions with respect to the role of these ribozymes in vivo. Group I intron-
derived ribozymes are essentially exon-less introns that mimic the final intron (L-IVS) 
product after self-splicing occurs. It has previously been shown that these spliced-out 
introns undergo intramolecular cyclization reactions, resulting in a predicted inactive, 
circular intron product. However, it is not known if these spliced-out introns can catalyze 
additional intramolecular transesterification reactions. This could include spliced-out 
introns catalyzing the TES reaction using additional RNA transcripts as substrates. If, 
however, these spliced-out introns catalyze the cleavage of RNA transcripts that code for 
essential protein products, this could have deleterious effects on a cell. With this in mind, 
the intramolecular cyclization reaction could have evolved to deactivate spliced-out 
introns from cleaving unintended RNA transcripts. 
 
The Trans Insertion-Splicing Reaction 
 The trans insertion-splicing (TIS) reaction has been envisioned as a new strategy 
for the construction of RNA transcripts with site-specific modifications. In this strategy, 
the Pneumocystis carinii ribozyme would be engineered to insert specific regions from 
within full-length RNA transcripts. In turn, these modified RNA transcripts could be 
useful for functional as well as structural studies of RNA in vitro and in vivo. The work 
presented herein has answered some of the questions relating to the feasibility of using 
the TIS reaction as a strategy for site-specific incorporation of modified oligonucleotides 
into RNA.  
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The Trans Insertion-Splicing Reaction can Catalyze the Insertion of Modified 
Oligonucleotides 
 The work presented herein has demonstrated that the TIS reaction is a viable 
strategy for the insertion of modified oligonucleotides into an RNA substrate. In the 
current study, key positions within a nucleotide were altered, including changes to the 2’ 
position of the sugar ring, the phosphodiester backbone, and the base positions. 
Modifications at each of these positions can be used as probes for investigating the 
underlying intricacies of a specific RNAs structure and function. For example, the TIS 
strategy could be useful for the insertion of spin labels for electron paramagnetic 
resonance (EPR) or for labeling RNA sequences with relevant isotopes for nuclear 
magnetic resonance (NMR) studies. In addition, TIS could be used for labeling RNA 
sequences with fluorescent probes for use in fluorescent resonance energy transfer 
(FRET) experiments. Finally, the role of post-transcriptionally modified RNA transcripts 
could be more thoroughly investigated through creation of these RNA transcripts using 
the TIS strategy. With the broad range of modified nucleotides that are commercially 
available, future TIS reactions could potentially open new avenues for the study of RNA. 
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